| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000002 | Mitochondrial genome maintenance | Decreases phenotype | PMID:30194976 |
| GO:0000045 | Autophagosome assembly | Increases phenotype | PMID:29275510 |
| GO:0000050 | Urea cycle | Increases phenotype | PMID:29477810 |
| GO:0000080 | Mitotic g1 phase | Affects phenotype | PMID:36633214 |
| GO:0000084 | Mitotic s phase | Increases phenotype | PMID:28736785; PMID:29846718; PMID:30467747; PMID:31601247; PMID:31916403; PMID:33516137; PMID:34585602; PMID:35429799; PMID:36982678; PMID:37105472; PMID:38211720; PMID:38372072 |
| GO:0000085 | Mitotic g2 phase | Affects phenotype | PMID:33516137; PMID:36181250 |
| GO:0000086 | G2/m transition of mitotic cell cycle | Decreases phenotype | PMID:30467747; PMID:31601247; PMID:31916403; PMID:36633214; PMID:38372072 |
| GO:0000089 | Mitotic metaphase | Affects phenotype | PMID:36384894 |
| GO:0000104 | Succinate dehydrogenase activity | Decreases phenotype | PMID:37718616 |
| GO:0000162 | Tryptophan biosynthetic process | Affects phenotype | PMID:28549143; PMID:34082316 |
| GO:0000236 | Mitotic prometaphase | Affects phenotype | PMID:30980863 |
| GO:0000262 | Mitochondrial chromosome | Decreases phenotype | PMID:36966614 |
| GO:0000266 | Mitochondrial fission | Increases phenotype | PMID:36549428 |
| GO:0000278 | Mitotic cell cycle | Increases phenotype | PMID:26397976; PMID:30467747; PMID:36608567 |
| GO:0000723 | Telomere maintenance | Affects phenotype | PMID:31004310; PMID:36966614 |
| GO:0000737 | Dna catabolic process, endonucleolytic | Increases phenotype | PMID:36633214 |
| GO:0001501 | Skeletal system development | Affects phenotype | PMID:30321649 |
| GO:0001503 | Ossification | Decreases phenotype | PMID:23900028 |
| GO:0001510 | Rna methylation | Increases phenotype | PMID:24433282; PMID:31146095; PMID:36451259; PMID:36469784; PMID:37495067; PMID:38354435 |
| GO:0001516 | Prostaglandin biosynthetic process | Affects phenotype | PMID:23672405; PMID:30609183 |
| GO:0001525 | Angiogenesis | Affects phenotype | PMID:35051763 |
| GO:0001541 | Ovarian follicle development | Decreases phenotype | PMID:24034936; PMID:24051130; PMID:24625398; PMID:24458533; PMID:27208089; PMID:30629253; PMID:31424294; PMID:32407858; PMID:33509759; PMID:37108581; PMID:39322090 |
| GO:0001544 | Initiation of primordial ovarian follicle growth | Decreases phenotype | PMID:26049153 |
| GO:0001546 | Preantral ovarian follicle growth | Decreases phenotype | PMID:33718757 |
| GO:0001547 | Antral ovarian follicle growth | Affects phenotype | PMID:24025742; PMID:31424294 |
| GO:0001548 | Follicular fluid formation in ovarian follicle antrum | Decreases phenotype | PMID:29958887 |
| GO:0001550 | Ovarian cumulus expansion | Decreases phenotype | PMID:29458137 |
| GO:0001551 | Ovarian follicle endowment | Decreases phenotype | PMID:26049153 |
| GO:0001552 | Ovarian follicle atresia | Increases phenotype | PMID:28648634; PMID:29958887; PMID:30675821; PMID:32407858; PMID:37448361 |
| GO:0001553 | Luteinization | Increases phenotype | PMID:24625398; PMID:26161573; PMID:30675821 |
| GO:0001556 | Oocyte maturation | Decreases phenotype | PMID:38736411 |
| GO:0001570 | Vasculogenesis | Decreases phenotype | PMID:31756439 |
| GO:0001649 | Osteoblast differentiation | Affects phenotype | PMID:23900028; PMID:34097993; PMID:34850234; PMID:35780740 |
| GO:0001662 | Behavioral fear response | Affects phenotype | PMID:22760093 |
| GO:0001787 | Natural killer cell proliferation | Increases phenotype | PMID:38431166 |
| GO:0001821 | Histamine secretion | Increases phenotype | PMID:22446810; PMID:23782309 |
| GO:0001824 | Blastocyst development | Affects phenotype | PMID:33246333 |
| GO:0001825 | Blastocyst formation | Decreases phenotype | PMID:25772901 |
| GO:0001836 | Release of cytochrome c from mitochondria | Increases phenotype | PMID:24768697; PMID:24905940; PMID:26096086; PMID:27189055 |
| GO:0001837 | Epithelial to mesenchymal transition | Increases phenotype | PMID:33469997 |
| GO:0001890 | Placenta development | Affects phenotype | PMID:23593014; PMID:30303745; PMID:32071231 |
| GO:0001891 | Phagocytic cup | Increases phenotype | PMID:35250464 |
| GO:0001892 | Embryonic placenta development | Affects phenotype | PMID:38431166 |
| GO:0001944 | Vasculature development | Increases phenotype | PMID:39322090 |
| GO:0001958 | Endochondral ossification | Decreases phenotype | PMID:34850234 |
| GO:0001966 | Thigmotaxis | Affects phenotype | PMID:35560535 |
| GO:0002027 | Regulation of heart rate | Affects phenotype | PMID:32144343 |
| GO:0002062 | Chondrocyte differentiation | Decreases phenotype | PMID:34850234 |
| GO:0002067 | Glandular epithelial cell differentiation | Affects phenotype | PMID:26898831 |
| GO:0002118 | Aggressive behavior | Affects phenotype | PMID:25307304 |
| GO:0002157 | Positive regulation of thyroid hormone mediated signaling pathway | Increases phenotype | PMID:29146198 |
| GO:0002209 | Behavioral defense response | Affects phenotype | PMID:38152552 |
| GO:0002265 | Astrocyte activation involved in immune response | Increases phenotype | PMID:24824810 |
| GO:0002377 | Immunoglobulin production | Increases phenotype | PMID:27087817 |
| GO:0002381 | Immunoglobulin production involved in immunoglobulin-mediated immune response | Increases phenotype | PMID:24950052; PMID:29737898 |
| GO:0002437 | Inflammatory response to antigenic stimulus | Increases phenotype | PMID:24950052; PMID:27087817 |
| GO:0002457 | T cell antigen processing and presentation | Increases phenotype | PMID:32810514 |
| GO:0002522 | Leukocyte migration involved in immune response | Affects phenotype | PMID:26496021; PMID:29737898 |
| GO:0002523 | Leukocyte migration involved in inflammatory response | Increases phenotype | PMID:27087817; PMID:28285737; PMID:28689058; PMID:33582552; PMID:36549428; PMID:36549428; PMID:37510359; PMID:38027817; PMID:39322090 |
| GO:0002534 | Cytokine production involved in inflammatory response | Increases phenotype | PMID:27087817 |
| GO:0002609 | Positive regulation of myeloid dendritic cell antigen processing and presentation | Increases phenotype | PMID:29737898 |
| GO:0002639 | Positive regulation of immunoglobulin production | Increases phenotype | PMID:29427786 |
| GO:0002693 | Positive regulation of cellular extravasation | Increases phenotype | PMID:28959593; PMID:29737898; PMID:30057697 |
| GO:0002925 | Positive regulation of humoral immune response mediated by circulating immunoglobulin | Increases phenotype | PMID:27869686 |
| GO:0002931 | Response to ischemia | Decreases phenotype | PMID:32319667 |
| GO:0003006 | Developmental process involved in reproduction | Increases phenotype | PMID:28750633; PMID:30629253; PMID:31132128; PMID:36508816 |
| GO:0003014 | Renal system process | Decreases phenotype | PMID:21147601 |
| GO:0003084 | Positive regulation of systemic arterial blood pressure | Increases phenotype | PMID:30496632; PMID:31489946 |
| GO:0003093 | Regulation of glomerular filtration | Affects phenotype | PMID:32645486 |
| GO:0003300 | Cardiac muscle hypertrophy | Increases phenotype | PMID:37611474 |
| GO:0003720 | Telomerase activity | Increases phenotype | PMID:26397976 |
| GO:0003756 | Protein disulfide isomerase activity | Decreases phenotype | PMID:25122773 |
| GO:0003990 | Acetylcholinesterase activity | Affects phenotype | PMID:34505250 |
| GO:0003994 | Aconitate hydratase activity | Decreases phenotype | PMID:33265944 |
| GO:0004021 | L-alanine:2-oxoglutarate aminotransferase activity | Increases phenotype | PMID:37211107; PMID:39260547; PMID:39722417 |
| GO:0004035 | Alkaline phosphatase activity | Increases phenotype | PMID:26450347; PMID:35890622; PMID:39722417; PMID:29477810; PMID:31733320; PMID:31979393; PMID:35780740; PMID:35945320; PMID:39722417 |
| GO:0004053 | Arginase activity | Increases phenotype | PMID:32172062 |
| GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity | Increases phenotype | PMID:28689058; PMID:28689058; PMID:35890622; PMID:36597173; PMID:39722417; PMID:29477810; PMID:31470036; PMID:37701206; PMID:31979393; PMID:34067838; PMID:35945320; PMID:36597173; PMID:37211107; PMID:37701206; PMID:39260547; PMID:39722417 |
| GO:0004096 | Catalase activity | Decreases phenotype | PMID:39722417 |
| GO:0004111 | Creatine kinase activity | Increases phenotype | PMID:30496632 |
| GO:0004129 | Cytochrome-c oxidase activity | Decreases phenotype | PMID:26450347; PMID:31387175 |
| GO:0004197 | Cysteine-type endopeptidase activity | Increases phenotype | PMID:34655688 |
| GO:0004359 | Glutaminase activity | Affects phenotype | PMID:34434659; PMID:37372067 |
| GO:0004362 | Glutathione-disulfide reductase (nadph) activity | Decreases phenotype | PMID:39549767 |
| GO:0004364 | Glutathione transferase activity | Affects phenotype | PMID:12030774; PMID:25112833; PMID:28959593; PMID:30057697; PMID:34505250; PMID:35945320; PMID:37843661; PMID:39260547 |
| GO:0004447 | Iodide peroxidase activity | Decreases phenotype | PMID:30352396 |
| GO:0004449 | Isocitrate dehydrogenase (nad+) activity | Decreases phenotype | PMID:37718616 |
| GO:0004457 | Lactate dehydrogenase activity | Increases phenotype | PMID:26450347; PMID:28689058; PMID:28689058; PMID:29477810; PMID:37084542; PMID:39117098 |
| GO:0004517 | Nitric-oxide synthase activity | Increases phenotype | PMID:32629208; PMID:33967032 |
| GO:0004602 | Glutathione peroxidase activity | Increases phenotype | PMID:18246544; PMID:21840368; PMID:22269103; PMID:22623521; PMID:22623521; PMID:38513920; PMID:24472609; PMID:25112833; PMID:31387175; PMID:31387175; PMID:33485121; PMID:36633214; PMID:31453682; PMID:33485121; PMID:36633214; PMID:37718616; PMID:37843661; PMID:38348715; PMID:38513920; PMID:39722417 |
| GO:0004679 | Amp-activated protein kinase activity | Decreases phenotype | PMID:30228064; PMID:34664771 |
| GO:0004784 | Superoxide dismutase activity | Affects phenotype | PMID:22269103; PMID:22623521; PMID:22623521; PMID:23024759; PMID:30997025; PMID:38513920; PMID:24472609; PMID:25112833; PMID:25112833; PMID:30641872; PMID:30997025; PMID:34067838; PMID:35890622; PMID:36597173; PMID:39722417; PMID:25454643; PMID:26450347; PMID:28285737; PMID:28285737; PMID:30997025; PMID:38027817; PMID:30641872; PMID:30641872; PMID:30997025; PMID:39722417; PMID:30997025; PMID:30997025; PMID:38348715; PMID:31064381; PMID:31387175; PMID:31387175; PMID:33173981; PMID:31387175; PMID:33485121; PMID:36633214; PMID:31424294; PMID:31453682; PMID:33265944; PMID:33485121; PMID:33582552; PMID:33967032; PMID:34067838; PMID:34097988; PMID:34793900; PMID:36597173; PMID:36633214; PMID:36966614; PMID:37718616; PMID:37843661; PMID:38027817; PMID:38348715; PMID:38513920; PMID:39059691; PMID:39722417 |
| GO:0005245 | Voltage-gated calcium channel activity | Increases phenotype | PMID:28924161; PMID:35457000 |
| GO:0005248 | Voltage-gated sodium channel activity | Affects phenotype | PMID:31250031; PMID:31312012 |
| GO:0005249 | Voltage-gated potassium channel activity | Decreases phenotype | PMID:31250031; PMID:35457000 |
| GO:0005391 | P-type sodium:potassium-exchanging transporter activity | Increases phenotype | PMID:37718616 |
| GO:0005911 | Cell-cell junction | Decreases phenotype | PMID:28808208 |
| GO:0005976 | Polysaccharide metabolic process | Affects phenotype | PMID:33582552 |
| GO:0005977 | Glycogen metabolic process | Affects phenotype | PMID:23748860; PMID:32623698 |
| GO:0005984 | Disaccharide metabolic process | Affects phenotype | PMID:32071231 |
| GO:0006000 | Fructose metabolic process | Affects phenotype | PMID:32071231 |
| GO:0006006 | Glucose metabolic process | Affects phenotype | PMID:32574892; PMID:35489422; PMID:35504408; PMID:38200540 |
| GO:0006007 | Glucose catabolic process | Decreases phenotype | PMID:29793316 |
| GO:0006071 | Glycerol metabolic process | Affects phenotype | PMID:35504408 |
| GO:0006089 | Lactate metabolic process | Affects phenotype | PMID:35560535 |
| GO:0006094 | Gluconeogenesis | Increases phenotype | PMID:25796683; PMID:28689058; PMID:30997025; PMID:31121516; PMID:37657410 |
| GO:0006096 | Glycolytic process | Decreases phenotype | PMID:28849599; PMID:34771623; PMID:36011004 |
| GO:0006105 | Succinate metabolic process | Affects phenotype | PMID:31121516 |
| GO:0006120 | Mitochondrial electron transport, nadh to ubiquinone | Increases phenotype | PMID:31344369 |
| GO:0006121 | Mitochondrial electron transport, succinate to ubiquinone | Increases phenotype | PMID:31344369 |
| GO:0006122 | Mitochondrial electron transport, ubiquinol to cytochrome c | Decreases phenotype | PMID:26450347; PMID:30841469; PMID:35598803 |
| GO:0006123 | Mitochondrial electron transport, cytochrome c to oxygen | Decreases phenotype | PMID:30841469; PMID:35598803 |
| GO:0006171 | Camp biosynthetic process | Affects phenotype | PMID:24140712; PMID:28858478; PMID:31126612; PMID:31212720; PMID:32126385 |
| GO:0006182 | Cgmp biosynthetic process | Affects phenotype | PMID:32629208 |
| GO:0006260 | Dna replication | Increases phenotype | PMID:31011801 |
| GO:0006264 | Mitochondrial dna replication | Affects phenotype | PMID:25101517; PMID:31387175; PMID:33173981 |
| GO:0006304 | Dna modification | Affects phenotype | PMID:30194976; PMID:30626059; PMID:31489946 |
| GO:0006306 | Dna methylation | Increases phenotype | PMID:23590724; PMID:23593014; PMID:23653003; PMID:23748860; PMID:24034936; PMID:25748669; PMID:28597690; PMID:31463084; PMID:32763279; PMID:35504408; PMID:36473650 |
| GO:0006338 | Chromatin remodeling | Increases phenotype | PMID:33916708; PMID:36549428 |
| GO:0006349 | Regulation of gene expression by genomic imprinting | Affects phenotype | PMID:29165653 |
| GO:0006355 | Regulation of dna-templated transcription | Affects phenotype | PMID:25853433; PMID:35005817 |
| GO:0006357 | Regulation of transcription by rna polymerase ii | Decreases phenotype | PMID:30001178 |
| GO:0006412 | Translation | Decreases phenotype | PMID:22125951 |
| GO:0006413 | Translational initiation | Decreases phenotype | PMID:33431410 |
| GO:0006486 | Protein glycosylation | Increases phenotype | PMID:32339907 |
| GO:0006497 | Protein lipidation | Increases phenotype | PMID:34186417; PMID:37257343 |
| GO:0006520 | Amino acid metabolic process | Affects phenotype | PMID:36432690 |
| GO:0006521 | Regulation of cellular amino acid metabolic process | Affects phenotype | PMID:27514991; PMID:28973422 |
| GO:0006523 | Alanine biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0006536 | Glutamate metabolic process | Affects phenotype | PMID:34434659; PMID:37372067 |
| GO:0006537 | Glutamate biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0006541 | Glutamine metabolic process | Affects phenotype | PMID:34434659 |
| GO:0006542 | Glutamine biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0006545 | Glycine biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0006556 | S-adenosylmethionine biosynthetic process | Increases phenotype | PMID:24449424 |
| GO:0006561 | Proline biosynthetic process | Increases phenotype | PMID:27514991 |
| GO:0006571 | Tyrosine biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0006577 | Amino-acid betaine metabolic process | Affects phenotype | PMID:31778932 |
| GO:0006590 | Thyroid hormone generation | Affects phenotype | PMID:30761779; PMID:30761779; PMID:31979393; PMID:31979393 |
| GO:0006600 | Creatine metabolic process | Affects phenotype | PMID:35192832 |
| GO:0006606 | Protein import into nucleus | Affects phenotype | PMID:32360864; PMID:33437163; PMID:37257343; PMID:37414130 |
| GO:0006629 | Lipid metabolic process | Increases phenotype | PMID:24755147; PMID:24768697; PMID:31820560; PMID:35622622; PMID:36597173; PMID:36632902; PMID:39742910 |
| GO:0006631 | Fatty acid metabolic process | Affects phenotype | PMID:24768697; PMID:32071231; PMID:33221593; PMID:34165232; PMID:34165232; PMID:35504408; PMID:34165232; PMID:35504408; PMID:37570835; PMID:35504408; PMID:36632902; PMID:36835180; PMID:37570835; PMID:37718616; PMID:38048832 |
| GO:0006633 | Fatty acid biosynthetic process | Increases phenotype | PMID:27014939; PMID:30145421; PMID:34165232 |
| GO:0006635 | Fatty acid beta-oxidation | Decreases phenotype | PMID:34165232 |
| GO:0006641 | Triglyceride metabolic process | Affects phenotype | PMID:24768697; PMID:31551937; PMID:34165232; PMID:35890622; PMID:36597173; PMID:31551937; PMID:31661889; PMID:34165232; PMID:37570835; PMID:31551937; PMID:34165232; PMID:35890622; PMID:36597173; PMID:31661889; PMID:31842455; PMID:32623698; PMID:32623698; PMID:33221593; PMID:37701206; PMID:37755785; PMID:32623698; PMID:37701206; PMID:37755785; PMID:33221593; PMID:33265944; PMID:34067838; PMID:34165232; PMID:34801515; PMID:36291063; PMID:36597173; PMID:36670177; PMID:37105096; PMID:37570835; PMID:37701206; PMID:37755785 |
| GO:0006665 | Sphingolipid metabolic process | Affects phenotype | PMID:33243495 |
| GO:0006672 | Ceramide metabolic process | Affects phenotype | PMID:38048832 |
| GO:0006693 | Prostaglandin metabolic process | Affects phenotype | PMID:38882385 |
| GO:0006694 | Steroid biosynthetic process | Decreases phenotype | PMID:24025742 |
| GO:0006695 | Cholesterol biosynthetic process | Affects phenotype | PMID:25168180; PMID:31470036; PMID:30997025; PMID:31126612; PMID:31270304; PMID:31470036; PMID:31979393 |
| GO:0006699 | Bile acid biosynthetic process | Increases phenotype | PMID:28549143 |
| GO:0006701 | Progesterone biosynthetic process | Affects phenotype | PMID:24769007; PMID:28859904; PMID:31063457; PMID:31424294 |
| GO:0006702 | Androgen biosynthetic process | Increases phenotype | PMID:23967237 |
| GO:0006703 | Estrogen biosynthetic process | Increases phenotype | PMID:24134786; PMID:28697429; PMID:28739533; PMID:24305612; PMID:24403293; PMID:24532816; PMID:24532816; PMID:24769007; PMID:28697429; PMID:28970132; PMID:29501275; PMID:31063457; PMID:31352099; PMID:31374317 |
| GO:0006749 | Glutathione metabolic process | Increases phenotype | PMID:27925325; PMID:30641872; PMID:33315269; PMID:35890622; PMID:27925325; PMID:30641872; PMID:35890622; PMID:28259788; PMID:30057697; PMID:30641872; PMID:30641872; PMID:31091348; PMID:31091348; PMID:31778932; PMID:36432690; PMID:31875995; PMID:32153214; PMID:32153214; PMID:37843661; PMID:32339907; PMID:32963736; PMID:33315269; PMID:34067838; PMID:35187753; PMID:35427877; PMID:35648353; PMID:35699857; PMID:36235125; PMID:36966614; PMID:37718616; PMID:37843661; PMID:38326183; PMID:38348715; PMID:39736419 |
| GO:0006750 | Glutathione biosynthetic process | Affects phenotype | PMID:21840368; PMID:22269103; PMID:22269103; PMID:24909818; PMID:22623521; PMID:24472609; PMID:24909818; PMID:25112833; PMID:25344109; PMID:25454643; PMID:26450347; PMID:28689058; PMID:28796629; PMID:30496632; PMID:30997025; PMID:30526071; PMID:30526071; PMID:30997025; PMID:30997025 |
| GO:0006751 | Glutathione catabolic process | Increases phenotype | PMID:38029875 |
| GO:0006754 | Atp biosynthetic process | Affects phenotype | PMID:24768697; PMID:24909818; PMID:25772901; PMID:26512966; PMID:28709040; PMID:28774890; PMID:29079494; PMID:30841469; PMID:31387175; PMID:31830493 |
| GO:0006757 | Atp generation from adp | Decreases phenotype | PMID:35598803 |
| GO:0006805 | Xenobiotic metabolic process | Increases phenotype | PMID:29162470 |
| GO:0006809 | Nitric oxide biosynthetic process | Increases phenotype | PMID:18246544; PMID:22446810; PMID:25103225; PMID:29964091; PMID:30609183; PMID:31416231; PMID:32629208 |
| GO:0006865 | Amino acid transport | Affects phenotype | PMID:32363662 |
| GO:0006874 | Cellular calcium ion homeostasis | Affects phenotype | PMID:31566189; PMID:31830493; PMID:33408296; PMID:33582411; PMID:34748853 |
| GO:0006909 | Phagocytosis | Decreases phenotype | PMID:26133781; PMID:30398665 |
| GO:0006914 | Autophagy | Increases phenotype | PMID:37257343 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:11906184; PMID:14703490; PMID:16909604; PMID:18521933; PMID:19193734; PMID:19193734; PMID:26863571; PMID:20807545; PMID:22269103; PMID:22269103; PMID:24905940; PMID:23788033; PMID:23900028; PMID:24134786; PMID:25461564; PMID:27296223; PMID:37915476; PMID:24156707; PMID:24257414; PMID:24464975; PMID:24464975; PMID:27189055; PMID:24809654; PMID:24884420; PMID:25454643; PMID:25461909; PMID:26397976; PMID:26512966; PMID:26512966; PMID:35563431; PMID:27174447; PMID:27189055; PMID:28446726; PMID:31489793; PMID:36451259; PMID:28910977; PMID:28928807; PMID:29846718; PMID:30467747; PMID:30841469; PMID:31201698; PMID:31263496; PMID:31400064; PMID:31453682; PMID:31489793; PMID:36451259; PMID:31629898; PMID:31756439; PMID:31916403; PMID:32407858; PMID:32714078; PMID:32753632; PMID:33509759; PMID:33582411; PMID:33771661; PMID:34186417; PMID:34434659; PMID:34439521; PMID:34537452; PMID:34585602; PMID:35187753; PMID:35219798; PMID:35439536; PMID:35461094; PMID:35461094; PMID:35563431; PMID:35563431; PMID:36181250; PMID:36442689; PMID:36451259; PMID:36549428; PMID:36613676; PMID:36966614; PMID:37009741; PMID:37257343; PMID:37394128; PMID:38372072; PMID:38421590; PMID:39216304 |
| GO:0006950 | Response to stress | Affects phenotype | PMID:35427877 |
| GO:0006954 | Inflammatory response | Increases phenotype | PMID:31788436; PMID:32012983; PMID:32144343; PMID:34067838; PMID:34281243; PMID:34838672; PMID:35622622; PMID:36466761; PMID:37570835 |
| GO:0006974 | Cellular response to dna damage stimulus | Affects phenotype | PMID:19591892; PMID:24901218; PMID:26916392; PMID:25344109; PMID:28446726; PMID:29477810; PMID:30526071; PMID:30678825; PMID:30841469; PMID:31207516; PMID:31489793; PMID:34434659; PMID:34585602; PMID:35219798 |
| GO:0006979 | Response to oxidative stress | Increases phenotype | PMID:12767684; PMID:24604882; PMID:34619205 |
| GO:0007005 | Mitochondrion organization | Decreases phenotype | PMID:24105817; PMID:25448896; PMID:25461564; PMID:30641872; PMID:31830493; PMID:36830956; PMID:36966614; PMID:38882385 |
| GO:0007028 | Cytoplasm organization | Decreases phenotype | PMID:25448896 |
| GO:0007033 | Vacuole organization | Increases phenotype | PMID:25448896; PMID:34434659; PMID:36549428 |
| GO:0007049 | Cell cycle | Decreases phenotype | PMID:11906184; PMID:15879462 |
| GO:0007058 | Spindle assembly involved in female meiosis ii | Decreases phenotype | PMID:29958887 |
| GO:0007094 | Mitotic spindle assembly checkpoint signaling | Increases phenotype | PMID:30980863 |
| GO:0007099 | Centriole replication | Increases phenotype | PMID:30980863 |
| GO:0007128 | Meiotic prophase i | Affects phenotype | PMID:40036665 |
| GO:0007129 | Homologous chromosome pairing at meiosis | Decreases phenotype | PMID:25181051 |
| GO:0007130 | Synaptonemal complex assembly | Affects phenotype | PMID:40036665 |
| GO:0007133 | Meiotic anaphase i | Increases phenotype | PMID:29458137 |
| GO:0007134 | Meiotic telophase i | Increases phenotype | PMID:29458137 |
| GO:0007137 | Meiotic metaphase ii | Increases phenotype | PMID:29458137 |
| GO:0007140 | Male meiotic nuclear division | Affects phenotype | PMID:22951085; PMID:24085620 |
| GO:0007141 | Male meiosis i | Decreases phenotype | PMID:23788033; PMID:25181051 |
| GO:0007144 | Female meiosis i | Affects phenotype | PMID:40036665 |
| GO:0007155 | Cell adhesion | Increases phenotype | PMID:25096985 |
| GO:0007166 | Cell surface receptor signaling pathway | Increases phenotype | PMID:28255459 |
| GO:0007202 | Activation of phospholipase c activity | Increases phenotype | PMID:24140712 |
| GO:0007204 | Positive regulation of cytosolic calcium ion concentration | Increases phenotype | PMID:29214717; PMID:29960846; PMID:30022450; PMID:30036487 |
| GO:0007214 | Gamma-aminobutyric acid signaling pathway | Affects phenotype | PMID:23791455 |
| GO:0007254 | Jnk cascade | Increases phenotype | PMID:24349194; PMID:29793316 |
| GO:0007267 | Cell-cell signaling | Decreases phenotype | PMID:28736254 |
| GO:0007281 | Germ cell development | Decreases phenotype | PMID:29741722; PMID:31532523 |
| GO:0007283 | Spermatogenesis | Decreases phenotype | PMID:22951085; PMID:25575453; PMID:29940534; PMID:27539358; PMID:30755151; PMID:29741722; PMID:30228064; PMID:30275377; PMID:31201698; PMID:31532523; PMID:31489793; PMID:36315628; PMID:32956838; PMID:34684636; PMID:35810996; PMID:36451259; PMID:38021376; PMID:36864339; PMID:37364641; PMID:37915476; PMID:38513920; PMID:38882385; PMID:39549767 |
| GO:0007286 | Spermatid development | Decreases phenotype | PMID:30245210 |
| GO:0007339 | Binding of sperm to zona pellucida | Decreases phenotype | PMID:28178360 |
| GO:0007340 | Acrosome reaction | Decreases phenotype | PMID:27125968 |
| GO:0007382 | Specification of segmental identity, maxillary segment | Decreases phenotype | PMID:31756439 |
| GO:0007409 | Axonogenesis | Decreases phenotype | PMID:33582411 |
| GO:0007416 | Synapse assembly | Affects phenotype | PMID:24820113 |
| GO:0007420 | Brain development | Decreases phenotype | PMID:24820113; PMID:33441873; PMID:31756439; PMID:33441873 |
| GO:0007507 | Heart development | Decreases phenotype | PMID:31756439 |
| GO:0007548 | Sex differentiation | Decreases phenotype | PMID:27841950; PMID:30001178 |
| GO:0007565 | Female pregnancy | Decreases phenotype | PMID:30629253 |
| GO:0007566 | Embryo implantation | Decreases phenotype | PMID:24769007; PMID:26026914; PMID:29605410; PMID:34831106; PMID:38431166 |
| GO:0007584 | Response to nutrient | Increases phenotype | PMID:31489946 |
| GO:0007610 | Behavior | Decreases phenotype | PMID:20049216; PMID:22543054; PMID:25307304; PMID:34788942; PMID:35560535; PMID:37926988 |
| GO:0007611 | Learning or memory | Decreases phenotype | PMID:24333847; PMID:34082316; PMID:37495067 |
| GO:0007612 | Learning | Decreases phenotype | PMID:24820113; PMID:32153214; PMID:32926169; PMID:33441873; PMID:37843661; PMID:35489422 |
| GO:0007613 | Memory | Decreases phenotype | PMID:24820113; PMID:30312744; PMID:33441873; PMID:33666843; PMID:37843661; PMID:38583549; PMID:39617347; PMID:30761779; PMID:31597243; PMID:32153214; PMID:32153214; PMID:38043803; PMID:32926169; PMID:33666843; PMID:34838597; PMID:34838597; PMID:35489422; PMID:36656826; PMID:37926988; PMID:38160929; PMID:38043803 |
| GO:0007614 | Short-term memory | Decreases phenotype | PMID:31064381 |
| GO:0007618 | Mating | Affects phenotype | PMID:30629253 |
| GO:0007623 | Circadian rhythm | Affects phenotype | PMID:34049886; PMID:36181250 |
| GO:0007625 | Grooming behavior | Decreases phenotype | PMID:33666843; PMID:39617347 |
| GO:0007631 | Feeding behavior | Affects phenotype | PMID:31979393; PMID:36633214; PMID:37105096 |
| GO:0008016 | Regulation of heart contraction | Affects phenotype | PMID:37567409 |
| GO:0008121 | Ubiquinol-cytochrome-c reductase activity | Decreases phenotype | PMID:31387175 |
| GO:0008137 | Nadh dehydrogenase (ubiquinone) activity | Decreases phenotype | PMID:22623521; PMID:26450347; PMID:30841469 |
| GO:0008152 | Metabolic process | Affects phenotype | PMID:22050967 |
| GO:0008177 | Succinate dehydrogenase (ubiquinone) activity | Decreases phenotype | PMID:21840368; PMID:22623521; PMID:24105817; PMID:26450347; PMID:31387175 |
| GO:0008184 | Glycogen phosphorylase activity | Decreases phenotype | PMID:26063408 |
| GO:0008202 | Steroid metabolic process | Affects phenotype | PMID:24563381 |
| GO:0008203 | Cholesterol metabolic process | Affects phenotype | PMID:23756648; PMID:31551937; PMID:31661889; PMID:31551937; PMID:31661889; PMID:33985639; PMID:31661889; PMID:31842455; PMID:33221593; PMID:37701206; PMID:33985639; PMID:34067838; PMID:34165232; PMID:34165232; PMID:35890622; PMID:36597173; PMID:36597173; PMID:37701206 |
| GO:0008206 | Bile acid metabolic process | Affects phenotype | PMID:33985639; PMID:36632902 |
| GO:0008210 | Estrogen metabolic process | Increases phenotype | PMID:24563381; PMID:32071231; PMID:32407858; PMID:32753632; PMID:35429613; PMID:33582552; PMID:33753083; PMID:33802611; PMID:34537452; PMID:34929288 |
| GO:0008217 | Regulation of blood pressure | Affects phenotype | PMID:22851732; PMID:32574892; PMID:33625709 |
| GO:0008219 | Cell death | Affects phenotype | PMID:25693136; PMID:26537420; PMID:26822619; PMID:27364615; PMID:30609183; PMID:32144343; PMID:32512148; PMID:35479511 |
| GO:0008234 | Cysteine-type peptidase activity | Increases phenotype | PMID:33312107; PMID:33916708; PMID:35461094; PMID:35563431; PMID:37372067 |
| GO:0008239 | Dipeptidyl-peptidase activity | Increases phenotype | PMID:32428650 |
| GO:0008253 | 5'-nucleotidase activity | Affects phenotype | PMID:32172062; PMID:32428650; PMID:32810514 |
| GO:0008283 | Cell population proliferation | Increases phenotype | PMID:15116845; PMID:15116845; PMID:18186328; PMID:24004914; PMID:24062438; PMID:24156707; PMID:24213142; PMID:24284790; PMID:24586459; PMID:24831732; PMID:25004094; PMID:25130739; PMID:27026707; PMID:28616630; PMID:28763032; PMID:28808208; PMID:17599374; PMID:18246544; PMID:18521933; PMID:18640724; PMID:26916392; PMID:19654912; PMID:20553123; PMID:22269103; PMID:22269103; PMID:24905940; PMID:24909818; PMID:28645579; PMID:22649256; PMID:24884420; PMID:23719110; PMID:23915859; PMID:23915859; PMID:24793927; PMID:24090592; PMID:24156707; PMID:24213142; PMID:25004094; PMID:25130739; PMID:28808208; PMID:24231368; PMID:24257414; PMID:24257414; PMID:32753632; PMID:24495410; PMID:24495410; PMID:24909818; PMID:24532171; PMID:24632125; PMID:24831732; PMID:24884420; PMID:24909818; PMID:25004094; PMID:25056133; PMID:25084756; PMID:25111128; PMID:25381574; PMID:25461909; PMID:25963729; PMID:26098999; PMID:26537420; PMID:26224478; PMID:26397976; PMID:26397976; PMID:29128613; PMID:26443714; PMID:26496021; PMID:26863571; PMID:26877094; PMID:26942597; PMID:27022677; PMID:27025157; PMID:27026707; PMID:28446726; PMID:28466560; PMID:28500084; PMID:28657538; PMID:28709040; PMID:28709040; PMID:37080528; PMID:28729173; PMID:28765096; PMID:28811233; PMID:28811233; PMID:33419253; PMID:28855101; PMID:28882636; PMID:28964603; PMID:29128613; PMID:29275510; PMID:29653259; PMID:33258555; PMID:30352284; PMID:30557795; PMID:30677511; PMID:30822521; PMID:30892605; PMID:31629898; PMID:31788436; PMID:32012983; PMID:32028606; PMID:32360864; PMID:32805339; PMID:33516137; PMID:34186418; PMID:36011004; PMID:36608567; PMID:37080528; PMID:37182577; PMID:37414130; PMID:37675141; PMID:37834465; PMID:38091676; PMID:38302795; PMID:38354435; PMID:38563870; PMID:38701888 |
| GO:0008284 | Positive regulation of cell population proliferation | Increases phenotype | PMID:23810794; PMID:25933419; PMID:25933419; PMID:27514991; PMID:28711546; PMID:28844962; PMID:29783106; PMID:35307500; PMID:35597549; PMID:26363202; PMID:27177772; PMID:27366082; PMID:27551335; PMID:27623287; PMID:27740625; PMID:27903287; PMID:28238728; PMID:28238728; PMID:30022450; PMID:28426875; PMID:28426875; PMID:29330934; PMID:32105160; PMID:28591870; PMID:28844962; PMID:28959593; PMID:29146198; PMID:29307715; PMID:29330934; PMID:29783106; PMID:30022450; PMID:30099086; PMID:30187510; PMID:30196065; PMID:31143956; PMID:31681507; PMID:32023790; PMID:32105160; PMID:33683587; PMID:34270681; PMID:34486460; PMID:35263089; PMID:38555994; PMID:38828452; PMID:39809339; PMID:40132786 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:29192164; PMID:29214717; PMID:29228121; PMID:29383186; PMID:29552716; PMID:29605410; PMID:29721103; PMID:29737898; PMID:30015891; PMID:30036487; PMID:30099677; PMID:30099677; PMID:32763284; PMID:32949729; PMID:30194976; PMID:30196065; PMID:30238673; PMID:30547568; PMID:32023790; PMID:32105160; PMID:32353385; PMID:32763284; PMID:32949729; PMID:33706241; PMID:34664771; PMID:34831106; PMID:34953956; PMID:35041905; PMID:35739755; PMID:36315628; PMID:36534918; PMID:38134982; PMID:38725370 |
| GO:0008286 | Insulin receptor signaling pathway | Decreases phenotype | PMID:24349194 |
| GO:0008291 | Acetylcholine metabolic process | Increases phenotype | PMID:35648353 |
| GO:0008292 | Acetylcholine biosynthetic process | Decreases phenotype | PMID:30761779 |
| GO:0008343 | Adult feeding behavior | Affects phenotype | PMID:31661889 |
| GO:0008344 | Adult locomotory behavior | Increases phenotype | PMID:34049886 |
| GO:0008361 | Regulation of cell size | Affects phenotype | PMID:27022676; PMID:33441873 |
| GO:0008395 | Steroid hydroxylase activity | Decreases phenotype | PMID:10879814; PMID:9708877 |
| GO:0008458 | Carnitine o-octanoyltransferase activity | Decreases phenotype | PMID:33265944 |
| GO:0008542 | Visual learning | Decreases phenotype | PMID:31064381; PMID:32629208; PMID:34838597; PMID:34838597; PMID:36656826 |
| GO:0008584 | Male gonad development | Affects phenotype | PMID:31201698; PMID:37164221; PMID:38882385; PMID:36864339 |
| GO:0008585 | Female gonad development | Affects phenotype | PMID:24576723; PMID:32156529 |
| GO:0008608 | Attachment of spindle microtubules to kinetochore | Affects phenotype | PMID:28178360 |
| GO:0008610 | Lipid biosynthetic process | Increases phenotype | PMID:26942597; PMID:26996129; PMID:30959087; PMID:26996129; PMID:27815650; PMID:28483554; PMID:30408883; PMID:31470036; PMID:34165232; PMID:36835180 |
| GO:0008652 | Amino acid biosynthetic process | Affects phenotype | PMID:31121516; PMID:31778932 |
| GO:0009060 | Aerobic respiration | Increases phenotype | PMID:29161229; PMID:30194976; PMID:36469784 |
| GO:0009070 | Serine family amino acid biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0009085 | Lysine biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0009088 | Threonine biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0009094 | L-phenylalanine biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0009097 | Isoleucine biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0009099 | Valine biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0009306 | Protein secretion | Decreases phenotype | PMID:35648353 |
| GO:0009395 | Phospholipid catabolic process | Increases phenotype | PMID:38029875 |
| GO:0009408 | Response to heat | Increases phenotype | PMID:31312012 |
| GO:0009437 | Carnitine metabolic process | Affects phenotype | PMID:38048832 |
| GO:0009441 | Glycolate metabolic process | Affects phenotype | PMID:32071231 |
| GO:0009448 | Gamma-aminobutyric acid metabolic process | Affects phenotype | PMID:39617347 |
| GO:0009566 | Fertilization | Decreases phenotype | PMID:25772901; PMID:28178360; PMID:28178360; PMID:36347119 |
| GO:0009749 | Response to glucose | Decreases phenotype | PMID:29175711 |
| GO:0009790 | Embryo development | Decreases phenotype | PMID:31756439; PMID:36347119 |
| GO:0009886 | Post-embryonic animal morphogenesis | Affects phenotype | PMID:22951085 |
| GO:0010001 | Glial cell differentiation | Increases phenotype | PMID:25381574; PMID:25963729 |
| GO:0010424 | Dna methylation on cytosine within a cg sequence | Increases phenotype | PMID:27312807; PMID:27334623; PMID:27415467; PMID:29721103; PMID:29721103; PMID:31451752; PMID:31601247; PMID:31906378; PMID:33022573; PMID:33391824; PMID:34089743; PMID:34788942; PMID:35504408; PMID:36469784; PMID:38898774 |
| GO:0010452 | Histone h3-k36 methylation | Affects phenotype | PMID:36347119; PMID:37315367 |
| GO:0010459 | Negative regulation of heart rate | Increases phenotype | PMID:22851732 |
| GO:0010467 | Gene expression | Affects phenotype | PMID:31004310 |
| GO:0010508 | Positive regulation of autophagy | Increases phenotype | PMID:27539358; PMID:35357751; PMID:38006930; PMID:38103660; PMID:38725370 |
| GO:0010536 | Positive regulation of activation of janus kinase activity | Increases phenotype | PMID:35699857 |
| GO:0010669 | Epithelial structure maintenance | Decreases phenotype | PMID:29903210; PMID:36315628 |
| GO:0010718 | Positive regulation of epithelial to mesenchymal transition | Increases phenotype | PMID:26546977; PMID:27480627; PMID:28844962; PMID:29323181; PMID:29718440; PMID:35597549; PMID:39809339 |
| GO:0010729 | Positive regulation of hydrogen peroxide biosynthetic process | Increases phenotype | PMID:39260547 |
| GO:0010742 | Macrophage derived foam cell differentiation | Increases phenotype | PMID:24755147 |
| GO:0010759 | Positive regulation of macrophage chemotaxis | Increases phenotype | PMID:25862758; PMID:28903498; PMID:29161229; PMID:29737898 |
| GO:0010761 | Fibroblast migration | Increases phenotype | PMID:35051763 |
| GO:0010801 | Negative regulation of peptidyl-threonine phosphorylation | Affects phenotype | PMID:30228064; PMID:34664771 |
| GO:0010811 | Positive regulation of cell-substrate adhesion | Increases phenotype | PMID:32559890 |
| GO:0010820 | Positive regulation of t cell chemotaxis | Increases phenotype | PMID:29161229; PMID:35533451 |
| GO:0010825 | Positive regulation of centrosome duplication | Increases phenotype | PMID:27998958 |
| GO:0010826 | Negative regulation of centrosome duplication | Decreases phenotype | PMID:27998958 |
| GO:0010867 | Positive regulation of triglyceride biosynthetic process | Increases phenotype | PMID:39260547 |
| GO:0010884 | Positive regulation of lipid storage | Increases phenotype | PMID:26944108; PMID:27273607; PMID:29410257; PMID:30133442; PMID:32353385; PMID:39537008 |
| GO:0010886 | Positive regulation of cholesterol storage | Increases phenotype | PMID:27502578 |
| GO:0010890 | Positive regulation of sequestering of triglyceride | Increases phenotype | PMID:26820058; PMID:27502578; PMID:32763284 |
| GO:0010906 | Regulation of glucose metabolic process | Affects phenotype | PMID:35739755; PMID:37364641 |
| GO:0010907 | Positive regulation of glucose metabolic process | Increases phenotype | PMID:36328215 |
| GO:0010917 | Negative regulation of mitochondrial membrane potential | Increases phenotype | PMID:32040846; PMID:33039870; PMID:34664771; PMID:35427877; PMID:38006930 |
| GO:0010918 | Positive regulation of mitochondrial membrane potential | Affects phenotype | PMID:25572651; PMID:32515636 |
| GO:0010940 | Positive regulation of necrotic cell death | Increases phenotype | PMID:29552716; PMID:30057697; PMID:35887390 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:25534675; PMID:26196221; PMID:27491884; PMID:27825933; PMID:28959593; PMID:29161229; PMID:29958887; PMID:30196065; PMID:30228064; PMID:32023790; PMID:33706241; PMID:34831106; PMID:38440074 |
| GO:0010952 | Positive regulation of peptidase activity | Increases phenotype | PMID:32428650 |
| GO:0010972 | Negative regulation of g2/m transition of mitotic cell cycle | Increases phenotype | PMID:35041905 |
| GO:0010975 | Regulation of neuron projection development | Affects phenotype | PMID:38750585 |
| GO:0010976 | Positive regulation of neuron projection development | Affects phenotype | PMID:27903287; PMID:37843801 |
| GO:0010983 | Positive regulation of high-density lipoprotein particle clearance | Increases phenotype | PMID:35945320; PMID:37211107; PMID:39260547 |
| GO:0010989 | Negative regulation of low-density lipoprotein particle clearance | Increases phenotype | PMID:35945320; PMID:37211107; PMID:39260547 |
| GO:0014002 | Astrocyte development | Decreases phenotype | PMID:35560535 |
| GO:0014008 | Positive regulation of microglia differentiation | Increases phenotype | PMID:29248573 |
| GO:0014063 | Negative regulation of serotonin secretion | Increases phenotype | PMID:34082316 |
| GO:0014808 | Release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | Increases phenotype | PMID:24140712 |
| GO:0014902 | Myotube differentiation | Decreases phenotype | PMID:29680376; PMID:38701888 |
| GO:0015705 | Iodide transport | Decreases phenotype | PMID:30352396 |
| GO:0015727 | Lactate transport | Affects phenotype | PMID:37080528 |
| GO:0015908 | Fatty acid transport | Affects phenotype | PMID:32623698 |
| GO:0015980 | Energy derivation by oxidation of organic compounds | Decreases phenotype | PMID:31536778 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:21840368; PMID:22623521; PMID:22623521; PMID:30526071; PMID:30997025; PMID:25111128; PMID:25112833; PMID:25454643; PMID:26450347; PMID:26788107; PMID:26822619; PMID:27296223; PMID:28285737; PMID:28285737; PMID:30997025; PMID:28689058; PMID:30496632; PMID:30997025; PMID:30526071; PMID:30526071; PMID:30997025; PMID:30641872; PMID:30641872; PMID:31091348; PMID:32172062; PMID:30997025; PMID:31064381; PMID:31091348; PMID:31387175; PMID:31424294; PMID:31453682; PMID:32172062; PMID:32701268; PMID:34067838; PMID:32810514; PMID:33265944; PMID:34067838; PMID:34097988 |
| GO:0016049 | Cell growth | Increases phenotype | PMID:26096086; PMID:26096086; PMID:28446726; PMID:28928807; PMID:29128613; PMID:30352284 |
| GO:0016209 | Antioxidant activity | Decreases phenotype | PMID:26376105; PMID:37682394 |
| GO:0016264 | Gap junction assembly | Decreases phenotype | PMID:29458137 |
| GO:0016358 | Dendrite development | Affects phenotype | PMID:24231043; PMID:32512148; PMID:35560535 |
| GO:0016477 | Cell migration | Affects phenotype | PMID:23915859; PMID:24997338; PMID:24997338; PMID:26407941; PMID:26027920; PMID:26363213; PMID:28709031; PMID:26407941; PMID:26604029; PMID:26855429; PMID:26869994; PMID:27025157; PMID:28466560; PMID:28709031; PMID:28709031; PMID:33437163; PMID:28808208; PMID:31230753; PMID:31629898; PMID:33437163; PMID:34910997; PMID:36011004 |
| GO:0016571 | Histone methylation | Affects phenotype | PMID:24533973; PMID:24604882 |
| GO:0016573 | Histone acetylation | Increases phenotype | PMID:24533973; PMID:25088689; PMID:25088689 |
| GO:0016615 | Malate dehydrogenase activity | Decreases phenotype | PMID:37718616 |
| GO:0016887 | Atp hydrolysis activity | Affects phenotype | PMID:26450347; PMID:29079494; PMID:30841469; PMID:31387175; PMID:32172062; PMID:32810514 |
| GO:0017014 | Protein nitrosylation | Increases phenotype | PMID:29960846 |
| GO:0018158 | Protein oxidation | Affects phenotype | PMID:25103225; PMID:26450347; PMID:29079494; PMID:31574244; PMID:34793900 |
| GO:0018910 | Benzene metabolic process | Affects phenotype | PMID:38734222 |
| GO:0019058 | Viral life cycle | Decreases phenotype | PMID:26684252 |
| GO:0019216 | Regulation of lipid metabolic process | Affects phenotype | PMID:27514991 |
| GO:0019228 | Neuronal action potential | Increases phenotype | PMID:31312012 |
| GO:0019233 | Sensory perception of pain | Affects phenotype | PMID:24189132 |
| GO:0019249 | Lactate biosynthetic process | Increases phenotype | PMID:25796683; PMID:28709040; PMID:30761779; PMID:31121516 |
| GO:0019369 | Arachidonic acid metabolic process | Affects phenotype | PMID:38882385 |
| GO:0019370 | Leukotriene biosynthetic process | Increases phenotype | PMID:23782309 |
| GO:0019413 | Acetate biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0019432 | Triglyceride biosynthetic process | Affects phenotype | PMID:23756648; PMID:24418828; PMID:24959901; PMID:24959901; PMID:28483554; PMID:28796629; PMID:31470036; PMID:25111128; PMID:25111128; PMID:28483554; PMID:28500084; PMID:25878060; PMID:27322340; PMID:28433925; PMID:28483554; PMID:28483554; PMID:31470036; PMID:28657538; PMID:30997025; PMID:28689058; PMID:28689058; PMID:31979393; PMID:30665118; PMID:30722647; PMID:30997025 |
| GO:0019627 | Urea metabolic process | Affects phenotype | PMID:39722417 |
| GO:0019695 | Choline metabolic process | Increases phenotype | PMID:24449424; PMID:31778932 |
| GO:0021703 | Locus ceruleus development | Affects phenotype | PMID:24985408 |
| GO:0021766 | Hippocampus development | Affects phenotype | PMID:32629208; PMID:33441873 |
| GO:0021860 | Pyramidal neuron development | Affects phenotype | PMID:30312744 |
| GO:0021915 | Neural tube development | Decreases phenotype | PMID:31756439 |
| GO:0022008 | Neurogenesis | Increases phenotype | PMID:17761398; PMID:25381574; PMID:25963729; PMID:35560535 |
| GO:0022602 | Ovulation cycle process | Affects phenotype | PMID:30629253; PMID:38200540 |
| GO:0022904 | Respiratory electron transport chain | Affects phenotype | PMID:24768697 |
| GO:0030010 | Establishment of cell polarity | Decreases phenotype | PMID:36608567 |
| GO:0030030 | Cell projection organization | Increases phenotype | PMID:25096985 |
| GO:0030032 | Lamellipodium assembly | Increases phenotype | PMID:37414130 |
| GO:0030036 | Actin cytoskeleton organization | Affects phenotype | PMID:32963737 |
| GO:0030042 | Actin filament depolymerization | Increases phenotype | PMID:24532171 |
| GO:0030073 | Insulin secretion | Increases phenotype | PMID:32339907 |
| GO:0030097 | Hemopoiesis | Increases phenotype | PMID:34067838 |
| GO:0030154 | Cell differentiation | Affects phenotype | PMID:27022677 |
| GO:0030182 | Neuron differentiation | Affects phenotype | PMID:25084756; PMID:25963729; PMID:28597690; PMID:31400064; PMID:37664457 |
| GO:0030186 | Melatonin metabolic process | Affects phenotype | PMID:36633214 |
| GO:0030199 | Collagen fibril organization | Affects phenotype | PMID:32370801; PMID:33265944; PMID:33582552; PMID:33912069; PMID:34281243; PMID:35051763; PMID:36466761; PMID:37570835; PMID:37718616; PMID:38027817 |
| GO:0030262 | Apoptotic nuclear changes | Increases phenotype | PMID:28959593 |
| GO:0030263 | Apoptotic chromosome condensation | Increases phenotype | PMID:30228064; PMID:33582411; PMID:34434659; PMID:36830956; PMID:37570835 |
| GO:0030282 | Bone mineralization | Increases phenotype | PMID:35780740 |
| GO:0030283 | Testosterone dehydrogenase [nad(p)] activity | Decreases phenotype | PMID:39313105; PMID:39549767 |
| GO:0030284 | Nuclear estrogen receptor activity | Increases phenotype | PMID:28255459 |
| GO:0030307 | Positive regulation of cell growth | Affects phenotype | PMID:27145005; PMID:27641926 |
| GO:0030316 | Osteoclast differentiation | Decreases phenotype | PMID:23900028 |
| GO:0030317 | Flagellated sperm motility | Decreases phenotype | PMID:24786630; PMID:25772901; PMID:27125968 |
| GO:0030324 | Lung development | Affects phenotype | PMID:26283537 |
| GO:0030325 | Adrenal gland development | Affects phenotype | PMID:24323913 |
| GO:0030335 | Positive regulation of cell migration | Increases phenotype | PMID:25534675; PMID:25690688; PMID:25690688; PMID:29718440; PMID:33683587; PMID:26546977; PMID:27366082; PMID:27480627; PMID:28844962; PMID:28844962; PMID:35597549; PMID:31143956; PMID:33683587; PMID:35597549; PMID:36232920; PMID:37308018; PMID:38555994; PMID:38828452; PMID:39809339; PMID:40132786 |
| GO:0030336 | Negative regulation of cell migration | Increases phenotype | PMID:34270681 |
| GO:0030432 | Peristalsis | Decreases phenotype | PMID:25884437 |
| GO:0030502 | Negative regulation of bone mineralization | Increases phenotype | PMID:35628159 |
| GO:0030511 | Positive regulation of transforming growth factor beta receptor signaling pathway | Increases phenotype | PMID:35069845 |
| GO:0030513 | Positive regulation of bmp signaling pathway | Increases phenotype | PMID:27740625 |
| GO:0030520 | Intracellular estrogen receptor signaling pathway | Increases phenotype | PMID:21831745; PMID:23211298; PMID:24284790; PMID:29192164; PMID:36513145 |
| GO:0030534 | Adult behavior | Affects phenotype | PMID:24857958 |
| GO:0030728 | Ovulation | Decreases phenotype | PMID:32407858 |
| GO:0030838 | Positive regulation of actin filament polymerization | Increases phenotype | PMID:39527977 |
| GO:0030861 | Negative regulation of polarized epithelial cell differentiation | Increases phenotype | PMID:35278557 |
| GO:0030879 | Mammary gland development | Decreases phenotype | PMID:24566421; PMID:28938483 |
| GO:0030889 | Negative regulation of b cell proliferation | Increases phenotype | PMID:29428349 |
| GO:0030954 | Astral microtubule nucleation | Increases phenotype | PMID:27998958 |
| GO:0030964 | Nadh dehydrogenase complex | Decreases phenotype | PMID:31387175 |
| GO:0031116 | Positive regulation of microtubule polymerization | Increases phenotype | PMID:27998958 |
| GO:0031175 | Neuron projection development | Affects phenotype | PMID:30953815; PMID:34838597 |
| GO:0031324 | Negative regulation of cellular metabolic process | Increases phenotype | PMID:32559890; PMID:34174261; PMID:35413382 |
| GO:0031394 | Positive regulation of prostaglandin biosynthetic process | Increases phenotype | PMID:33706241 |
| GO:0031532 | Actin cytoskeleton reorganization | Increases phenotype | PMID:31629898 |
| GO:0031547 | Brain-derived neurotrophic factor receptor signaling pathway | Affects phenotype | PMID:23185968 |
| GO:0031585 | Regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity | Increases phenotype | PMID:24140712 |
| GO:0031589 | Cell-substrate adhesion | Affects phenotype | PMID:32466334; PMID:32670863; PMID:34801682 |
| GO:0031669 | Cellular response to nutrient levels | Increases phenotype | PMID:27623287 |
| GO:0031941 | Filamentous actin | Decreases phenotype | PMID:32963737; PMID:36206637 |
| GO:0031987 | Locomotion involved in locomotory behavior | Increases phenotype | PMID:30761779; PMID:32297422; PMID:32810514; PMID:32926169; PMID:33666843; PMID:33666843; PMID:39617347; PMID:37843661; PMID:38152552 |
| GO:0032024 | Positive regulation of insulin secretion | Increases phenotype | PMID:35622622; PMID:38844119 |
| GO:0032125 | Micronucleus organization | Increases phenotype | PMID:30678825; PMID:35395335; PMID:39515574 |
| GO:0032148 | Activation of protein kinase b activity | Increases phenotype | PMID:27176707; PMID:27539358; PMID:30228064; PMID:29161229; PMID:29330934; PMID:29793316; PMID:30036487; PMID:30133442; PMID:30194976; PMID:30228064; PMID:31536778; PMID:32559890 |
| GO:0032205 | Negative regulation of telomere maintenance | Increases phenotype | PMID:29643374 |
| GO:0032275 | Luteinizing hormone secretion | Increases phenotype | PMID:24786630 |
| GO:0032278 | Positive regulation of gonadotropin secretion | Increases phenotype | PMID:31278978; PMID:35220427 |
| GO:0032334 | Inhibin secretion | Decreases phenotype | PMID:28637469 |
| GO:0032355 | Response to estradiol | Decreases phenotype | PMID:26898831; PMID:32319667 |
| GO:0032466 | Negative regulation of cytokinesis | Increases phenotype | PMID:35041905 |
| GO:0032613 | Interleukin-10 production | Increases phenotype | PMID:24189131 |
| GO:0032620 | Interleukin-17 production | Increases phenotype | PMID:24189131 |
| GO:0032623 | Interleukin-2 production | Increases phenotype | PMID:24189131 |
| GO:0032755 | Positive regulation of interleukin-6 production | Increases phenotype | PMID:33315269 |
| GO:0032760 | Positive regulation of tumor necrosis factor production | Increases phenotype | PMID:33315269; PMID:35699857 |
| GO:0032774 | Rna biosynthetic process | Decreases phenotype | PMID:22125951 |
| GO:0032776 | Dna methylation on cytosine | Affects phenotype | PMID:30196065; PMID:32636712; PMID:36347119 |
| GO:0032780 | Negative regulation of atp-dependent activity | Increases phenotype | PMID:32428650 |
| GO:0032781 | Positive regulation of atp-dependent activity | Increases phenotype | PMID:32428650 |
| GO:0032869 | Cellular response to insulin stimulus | Decreases phenotype | PMID:29935216; PMID:34186270 |
| GO:0032874 | Positive regulation of stress-activated mapk cascade | Increases phenotype | PMID:23900028 |
| GO:0032922 | Circadian regulation of gene expression | Affects phenotype | PMID:33297044 |
| GO:0032930 | Positive regulation of superoxide anion generation | Increases phenotype | PMID:29214717; PMID:33348264; PMID:38029875; PMID:39260547 |
| GO:0032945 | Negative regulation of mononuclear cell proliferation | Increases phenotype | PMID:29428349 |
| GO:0032956 | Regulation of actin cytoskeleton organization | Decreases phenotype | PMID:38828519 |
| GO:0032964 | Collagen biosynthetic process | Increases phenotype | PMID:27025157 |
| GO:0032967 | Positive regulation of collagen biosynthetic process | Increases phenotype | PMID:27177772 |
| GO:0033077 | T cell differentiation in thymus | Affects phenotype | PMID:35752395 |
| GO:0033123 | Positive regulation of purine nucleotide catabolic process | Increases phenotype | PMID:24449424 |
| GO:0033147 | Negative regulation of intracellular estrogen receptor signaling pathway | Increases phenotype | PMID:29958887 |
| GO:0033148 | Positive regulation of intracellular estrogen receptor signaling pathway | Affects phenotype | PMID:25371027; PMID:26139245; PMID:26898831; PMID:27366082; PMID:27473340; PMID:28711546; PMID:29330934; PMID:29330934; PMID:31388671; PMID:34831106 |
| GO:0033183 | Negative regulation of histone ubiquitination | Increases phenotype | PMID:35567931 |
| GO:0033192 | Calmodulin-dependent protein phosphatase activity | Increases phenotype | PMID:31830493 |
| GO:0033313 | Meiotic cell cycle checkpoint signaling | Affects phenotype | PMID:23788033; PMID:29458137 |
| GO:0033327 | Leydig cell differentiation | Affects phenotype | PMID:29524480; PMID:31201698; PMID:35810996 |
| GO:0033574 | Response to testosterone | Decreases phenotype | PMID:29778459 |
| GO:0033685 | Negative regulation of luteinizing hormone secretion | Increases phenotype | PMID:39239657 |
| GO:0033686 | Positive regulation of luteinizing hormone secretion | Increases phenotype | PMID:37448361 |
| GO:0034063 | Stress granule assembly | Increases phenotype | PMID:33431410; PMID:38734221 |
| GO:0034103 | Regulation of tissue remodeling | Affects phenotype | PMID:25862758 |
| GO:0034109 | Homotypic cell-cell adhesion | Increases phenotype | PMID:34049886; PMID:37610061 |
| GO:0034116 | Positive regulation of heterotypic cell-cell adhesion | Increases phenotype | PMID:33683587 |
| GO:0034144 | Negative regulation of toll-like receptor 4 signaling pathway | Increases phenotype | PMID:33706241 |
| GO:0034197 | Triglyceride transport | Affects phenotype | PMID:34801515 |
| GO:0034199 | Activation of protein kinase a activity | Increases phenotype | PMID:24140712 |
| GO:0034377 | Plasma lipoprotein particle assembly | Affects phenotype | PMID:30057697 |
| GO:0034389 | Lipid droplet organization | Increases phenotype | PMID:26820058 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:27539358; PMID:27539358; PMID:29940534; PMID:27539358; PMID:32339907; PMID:27925325; PMID:30057697; PMID:27925325; PMID:30057697; PMID:36597173; PMID:28202054; PMID:28259788; PMID:29793316; PMID:29940534; PMID:30036487; PMID:30057697; PMID:32040846; PMID:32428650; PMID:32963736; PMID:37843661; PMID:33173981; PMID:33315269; PMID:34664771; PMID:34797181; PMID:35648353; PMID:36432690; PMID:36597173; PMID:36632902; PMID:37718616; PMID:37843661; PMID:38326183; PMID:38348715; PMID:38882385 |
| GO:0034454 | Microtubule anchoring at centrosome | Increases phenotype | PMID:27998958 |
| GO:0034501 | Protein localization to kinetochore | Affects phenotype | PMID:30980863 |
| GO:0034698 | Response to gonadotropin | Affects phenotype | PMID:28648634 |
| GO:0034772 | Histone h4-k20 dimethylation | Decreases phenotype | PMID:40036665 |
| GO:0035066 | Positive regulation of histone acetylation | Increases phenotype | PMID:27182052 |
| GO:0035115 | Embryonic forelimb morphogenesis | Affects phenotype | PMID:31756439 |
| GO:0035116 | Embryonic hindlimb morphogenesis | Decreases phenotype | PMID:31756439 |
| GO:0035148 | Tube formation | Increases phenotype | PMID:24632125; PMID:30352284 |
| GO:0035176 | Social behavior | Increases phenotype | PMID:20691692; PMID:28641223; PMID:31188430; PMID:28747197; PMID:30580332; PMID:33666843; PMID:30761779; PMID:32297422; PMID:32518293; PMID:33666843; PMID:34049886 |
| GO:0035640 | Exploration behavior | Decreases phenotype | PMID:32450286; PMID:38152552; PMID:39617347 |
| GO:0035641 | Locomotory exploration behavior | Increases phenotype | PMID:24820113; PMID:33666843 |
| GO:0035702 | Monocyte homeostasis | Affects phenotype | PMID:37510359 |
| GO:0035774 | Positive regulation of insulin secretion involved in cellular response to glucose stimulus | Increases phenotype | PMID:27836638 |
| GO:0035794 | Positive regulation of mitochondrial membrane permeability | Increases phenotype | PMID:30196065 |
| GO:0035809 | Regulation of urine volume | Affects phenotype | PMID:29477810 |
| GO:0035847 | Uterine epithelium development | Increases phenotype | PMID:24769007; PMID:27473340 |
| GO:0035934 | Corticosterone secretion | Increases phenotype | PMID:24323913; PMID:38152552 |
| GO:0035936 | Testosterone secretion | Increases phenotype | PMID:24024361; PMID:24786630; PMID:24945889; PMID:30755151; PMID:31201698; PMID:31532523; PMID:35427877 |
| GO:0035937 | Estrogen secretion | Affects phenotype | PMID:33258555 |
| GO:0035938 | Estradiol secretion | Increases phenotype | PMID:24786630; PMID:29275510; PMID:30817981; PMID:31075703; PMID:31132128; PMID:31201698; PMID:31532523; PMID:31697385 |
| GO:0036098 | Male germ-line stem cell population maintenance | Increases phenotype | PMID:30245210 |
| GO:0036123 | Histone h3-k9 dimethylation | Increases phenotype | PMID:36347119 |
| GO:0036124 | Histone h3-k9 trimethylation | Decreases phenotype | PMID:24034936; PMID:28765096; PMID:36347119; PMID:36572933 |
| GO:0036126 | Sperm flagellum | Affects phenotype | PMID:38882385 |
| GO:0036128 | Catsper complex | Decreases phenotype | PMID:27125968 |
| GO:0036164 | Cell-abiotic substrate adhesion | Decreases phenotype | PMID:33024228 |
| GO:0036211 | Protein modification process | Increases phenotype | PMID:30953815 |
| GO:0036269 | Swimming behavior | Affects phenotype | PMID:32518293 |
| GO:0036440 | Citrate synthase activity | Decreases phenotype | PMID:31344369 |
| GO:0036446 | Myofibroblast differentiation | Increases phenotype | PMID:35051763 |
| GO:0038179 | Neurotrophin signaling pathway | Affects phenotype | PMID:23185968 |
| GO:0040015 | Negative regulation of multicellular organism growth | Increases phenotype | PMID:35278557 |
| GO:0040016 | Embryonic cleavage | Decreases phenotype | PMID:36347119 |
| GO:0040018 | Positive regulation of multicellular organism growth | Affects phenotype | PMID:27143994; PMID:27641926; PMID:29596923; PMID:32145629 |
| GO:0040029 | Epigenetic regulation of gene expression | Affects phenotype | PMID:31532523; PMID:33391824; PMID:38338858 |
| GO:0040038 | Polar body extrusion after meiotic divisions | Affects phenotype | PMID:28178360 |
| GO:0042023 | Dna endoreduplication | Increases phenotype | PMID:26027920 |
| GO:0042048 | Olfactory behavior | Increases phenotype | PMID:30185693 |
| GO:0042098 | T cell proliferation | Increases phenotype | PMID:38431166 |
| GO:0042110 | T cell activation | Affects phenotype | PMID:35752395 |
| GO:0042116 | Macrophage activation | Increases phenotype | PMID:28500084; PMID:31108126; PMID:32144343; PMID:37510359 |
| GO:0042117 | Monocyte activation | Increases phenotype | PMID:37510359 |
| GO:0042127 | Regulation of cell population proliferation | Affects phenotype | PMID:30196065; PMID:37084542 |
| GO:0042133 | Neurotransmitter metabolic process | Affects phenotype | PMID:32027964 |
| GO:0042138 | Meiotic dna double-strand break formation | Increases phenotype | PMID:23788033; PMID:24085620 |
| GO:0042157 | Lipoprotein metabolic process | Increases phenotype | PMID:32339907; PMID:32540565 |
| GO:0042158 | Lipoprotein biosynthetic process | Increases phenotype | PMID:37837293 |
| GO:0042168 | Heme metabolic process | Affects phenotype | PMID:29627605; PMID:30057697 |
| GO:0042305 | Specification of segmental identity, mandibular segment | Decreases phenotype | PMID:31756439 |
| GO:0042307 | Positive regulation of protein import into nucleus | Increases phenotype | PMID:27684650; PMID:29214717; PMID:29307715; PMID:30022450 |
| GO:0042310 | Vasoconstriction | Increases phenotype | PMID:36385337 |
| GO:0042393 | Histone binding | Increases phenotype | PMID:33022573 |
| GO:0042403 | Thyroid hormone metabolic process | Affects phenotype | PMID:34314248; PMID:37915476 |
| GO:0042414 | Epinephrine metabolic process | Affects phenotype | PMID:33912069 |
| GO:0042417 | Dopamine metabolic process | Affects phenotype | PMID:32071231; PMID:33666843; PMID:33666843; PMID:39617347; PMID:34505250 |
| GO:0042428 | Serotonin metabolic process | Increases phenotype | PMID:23567477; PMID:32071231; PMID:33666843; PMID:33666843; PMID:39617347; PMID:34505250 |
| GO:0042445 | Hormone metabolic process | Affects phenotype | PMID:20797929 |
| GO:0042448 | Progesterone metabolic process | Affects phenotype | PMID:32407858; PMID:33582552; PMID:34929288; PMID:35429613 |
| GO:0042452 | Deoxyguanosine biosynthetic process | Affects phenotype | PMID:35622622 |
| GO:0042531 | Positive regulation of tyrosine phosphorylation of stat protein | Increases phenotype | PMID:35699857 |
| GO:0042540 | Hemoglobin catabolic process | Increases phenotype | PMID:30057697 |
| GO:0042552 | Myelination | Decreases phenotype | PMID:25084756; PMID:27364615 |
| GO:0042554 | Superoxide anion generation | Increases phenotype | PMID:25103225; PMID:26450347; PMID:33024228; PMID:34793900; PMID:37718616 |
| GO:0042593 | Glucose homeostasis | Decreases phenotype | PMID:24705360; PMID:27502578; PMID:28959593; PMID:29935216; PMID:30057697; PMID:38042274 |
| GO:0042630 | Behavioral response to water deprivation | Affects phenotype | PMID:35644309 |
| GO:0042632 | Cholesterol homeostasis | Decreases phenotype | PMID:27502578; PMID:32540565; PMID:27641926; PMID:28959593; PMID:30057697; PMID:32540565; PMID:33243495; PMID:33315269; PMID:33315269; PMID:34505250; PMID:33315269; PMID:34505250; PMID:36137816; PMID:34505250; PMID:35341816; PMID:35622622; PMID:35739755; PMID:36137816 |
| GO:0042701 | Progesterone secretion | Increases phenotype | PMID:23672405; PMID:31075703; PMID:33258555; PMID:37182577 |
| GO:0042713 | Sperm ejaculation | Decreases phenotype | PMID:19906654 |
| GO:0042733 | Embryonic digit morphogenesis | Affects phenotype | PMID:38898774 |
| GO:0042756 | Drinking behavior | Affects phenotype | PMID:31661889; PMID:31979393; PMID:35644309 |
| GO:0042775 | Mitochondrial atp synthesis coupled electron transport | Decreases phenotype | PMID:25572651 |
| GO:0042800 | Histone h3k4 methyltransferase activity | Affects phenotype | PMID:31610501 |
| GO:0042866 | Pyruvate biosynthetic process | Affects phenotype | PMID:28709040; PMID:30761779 |
| GO:0042908 | Xenobiotic transport | Increases phenotype | PMID:29961922 |
| GO:0042994 | Cytoplasmic sequestering of transcription factor | Increases phenotype | PMID:27745655 |
| GO:0043011 | Myeloid dendritic cell differentiation | Decreases phenotype | PMID:29428349 |
| GO:0043025 | Neuronal cell body | Increases phenotype | PMID:30953815; PMID:33441873 |
| GO:0043032 | Positive regulation of macrophage activation | Increases phenotype | PMID:31143956; PMID:33239236; PMID:38828452 |
| GO:0043046 | Dna methylation involved in gamete generation | Affects phenotype | PMID:28582417 |
| GO:0043061 | Meiotic metaphase ii plate congression | Decreases phenotype | PMID:29958887 |
| GO:0043065 | Positive regulation of apoptotic process | Affects phenotype | PMID:24189131; PMID:25181051; PMID:26049153; PMID:26320837; PMID:27539358; PMID:27623287; PMID:27925325; PMID:33847390; PMID:35887390; PMID:29214717; PMID:29552716; PMID:38006930; PMID:30036487; PMID:32488702; PMID:32515636; PMID:33039870; PMID:34664771; PMID:35567931; PMID:37682394; PMID:35648353; PMID:35739755; PMID:35940389; PMID:36315628; PMID:36858637; PMID:37105472; PMID:37364641; PMID:37682394; PMID:38006930; PMID:38134982; PMID:38440074; PMID:38538260; PMID:38725370; PMID:38844119; PMID:39117098; PMID:39260547 |
| GO:0043066 | Negative regulation of apoptotic process | Increases phenotype | PMID:38828452 |
| GO:0043084 | Penile erection | Decreases phenotype | PMID:19906654; PMID:20467048 |
| GO:0043123 | Positive regulation of i-kappab kinase/nf-kappab signaling | Increases phenotype | PMID:29793316 |
| GO:0043149 | Stress fiber assembly | Increases phenotype | PMID:25096985; PMID:37414130 |
| GO:0043197 | Dendritic spine | Decreases phenotype | PMID:34838597; PMID:38043803 |
| GO:0043262 | Adp phosphatase activity | Affects phenotype | PMID:32172062; PMID:32428650; PMID:32810514 |
| GO:0043306 | Positive regulation of mast cell degranulation | Increases phenotype | PMID:31551929 |
| GO:0043408 | Regulation of mapk cascade | Increases phenotype | PMID:24231043 |
| GO:0043491 | Protein kinase b signaling | Increases phenotype | PMID:24464975 |
| GO:0043507 | Positive regulation of jun kinase activity | Increases phenotype | PMID:23900028 |
| GO:0043513 | Inhibin b complex | Increases phenotype | PMID:33256105 |
| GO:0043929 | Primary ovarian follicle growth involved in double layer follicle stage | Decreases phenotype | PMID:30675821 |
| GO:0043966 | Histone h3 acetylation | Increases phenotype | PMID:25748669; PMID:27697584; PMID:28496034; PMID:29718165 |
| GO:0043967 | Histone h4 acetylation | Increases phenotype | PMID:25748669; PMID:36572933 |
| GO:0043970 | Histone h3-k9 acetylation | Affects phenotype | PMID:28765096; PMID:34097993; PMID:34838597; PMID:34910997; PMID:36347119 |
| GO:0043974 | Histone h3-k27 acetylation | Affects phenotype | PMID:36306618 |
| GO:0044022 | Histone h3s28 kinase activity | Affects phenotype | PMID:36347119 |
| GO:0044029 | Hypomethylation of cpg island | Increases phenotype | PMID:27478869; PMID:30352284 |
| GO:0044030 | Regulation of dna methylation | Decreases phenotype | PMID:25853433; PMID:30001178; PMID:38338858 |
| GO:0044154 | Histone h3-k14 acetylation | Increases phenotype | PMID:36347119 |
| GO:0044237 | Cellular metabolic process | Increases phenotype | PMID:30467747; PMID:30467747; PMID:30552153; PMID:31601247; PMID:33181973; PMID:33376534; PMID:37315367; PMID:30552153; PMID:30615907; PMID:30841469; PMID:31016847; PMID:31400064; PMID:31601247; PMID:31610501; PMID:31714645; PMID:31715268; PMID:31733320; PMID:31812737; PMID:31830493; PMID:31916403; PMID:32144343; PMID:32244372; PMID:32363662; PMID:32512148; PMID:32610363; PMID:32636712; PMID:32753632; PMID:32963737; PMID:32976987; PMID:33024228; PMID:33181973; PMID:33376534; PMID:33441873; PMID:33509759; PMID:33582411; PMID:33662508; PMID:33771661; PMID:33841860; PMID:33916708; PMID:34186417; PMID:34439521; PMID:34474090; PMID:34602561; PMID:34655688; PMID:34743013; PMID:34748853; PMID:38211720; PMID:34910997; PMID:34929288; PMID:35219798; PMID:35457000; PMID:35461094; PMID:35563431; PMID:35996481; PMID:36181250; PMID:36277366; PMID:36306618; PMID:36336871; PMID:36466761; PMID:36549428; PMID:36613676; PMID:36674557; PMID:36982678; PMID:37009741; PMID:37080528; PMID:37143426; PMID:37257343; PMID:37315367; PMID:37372067; PMID:37394128; PMID:37610061; PMID:37915476; PMID:38211720; PMID:38326183; PMID:38372072; PMID:38421590; PMID:38701888; PMID:38892447; PMID:39216304; PMID:39736419 |
| GO:0044255 | Cellular lipid metabolic process | Increases phenotype | PMID:24472609; PMID:34323617 |
| GO:0044307 | Dendritic branch | Increases phenotype | PMID:34838597 |
| GO:0044319 | Wound healing, spreading of cells | Increases phenotype | PMID:25312822; PMID:25784559; PMID:27038254; PMID:27038254; PMID:28858478; PMID:32325111; PMID:28858478; PMID:30611077; PMID:31601247; PMID:32012983; PMID:32325111; PMID:32360864; PMID:32981897; PMID:33419253; PMID:33469997; PMID:34743013; PMID:35051763; PMID:37080528; PMID:37414130; PMID:38372072 |
| GO:0044381 | Glucose import in response to insulin stimulus | Increases phenotype | PMID:31536778 |
| GO:0044527 | Formation of peptidyl-cystine persulfide by sulphur transfer from h2s | Decreases phenotype | PMID:34314248 |
| GO:0044565 | Dendritic cell proliferation | Increases phenotype | PMID:29428349 |
| GO:0044648 | Histone h3-k4 dimethylation | Increases phenotype | PMID:25748669; PMID:35429613; PMID:36347119 |
| GO:0044849 | Estrous cycle | Affects phenotype | PMID:31132128; PMID:36136478 |
| GO:0045019 | Negative regulation of nitric oxide biosynthetic process | Increases phenotype | PMID:32428650 |
| GO:0045023 | G0 to g1 transition | Increases phenotype | PMID:30467747; PMID:31916403; PMID:35429799; PMID:36982678; PMID:38372072 |
| GO:0045333 | Cellular respiration | Decreases phenotype | PMID:33265944; PMID:34771623; PMID:36011004; PMID:37657410 |
| GO:0045348 | Positive regulation of mhc class ii biosynthetic process | Increases phenotype | PMID:29737898 |
| GO:0045429 | Positive regulation of nitric oxide biosynthetic process | Increases phenotype | PMID:29718165; PMID:29960846; PMID:30238673; PMID:32559890; PMID:33706241; PMID:34505250; PMID:37715411; PMID:38042274; PMID:38369087; PMID:39260547 |
| GO:0045444 | Fat cell differentiation | Increases phenotype | PMID:24155963; PMID:24418828; PMID:24503497; PMID:25068083; PMID:26942597; PMID:26996129; PMID:25143472; PMID:26996129; PMID:30408883; PMID:30665118; PMID:33254826; PMID:34186270; PMID:36469784; PMID:37105096 |
| GO:0045454 | Cell redox homeostasis | Decreases phenotype | PMID:38103660; PMID:39260547 |
| GO:0045542 | Positive regulation of cholesterol biosynthetic process | Increases phenotype | PMID:38029875; PMID:39260547 |
| GO:0045600 | Positive regulation of fat cell differentiation | Increases phenotype | PMID:26820058; PMID:26944108; PMID:27145005; PMID:27273607 |
| GO:0045723 | Positive regulation of fatty acid biosynthetic process | Increases phenotype | PMID:38029875 |
| GO:0045738 | Negative regulation of dna repair | Increases phenotype | PMID:33239236 |
| GO:0045741 | Positive regulation of epidermal growth factor-activated receptor activity | Increases phenotype | PMID:30022450 |
| GO:0045766 | Positive regulation of angiogenesis | Increases phenotype | PMID:37224931 |
| GO:0045777 | Positive regulation of blood pressure | Affects phenotype | PMID:33315269 |
| GO:0045793 | Positive regulation of cell size | Increases phenotype | PMID:28244015; PMID:28774890; PMID:36469784 |
| GO:0045795 | Positive regulation of cell volume | Increases phenotype | PMID:31830493; PMID:37755785 |
| GO:0045821 | Positive regulation of glycolytic process | Increases phenotype | PMID:31536778; PMID:36328215 |
| GO:0045880 | Positive regulation of smoothened signaling pathway | Increases phenotype | PMID:29307715 |
| GO:0045919 | Positive regulation of cytolysis | Increases phenotype | PMID:35220427; PMID:36235125 |
| GO:0045930 | Negative regulation of mitotic cell cycle | Increases phenotype | PMID:26604029; PMID:29383186; PMID:30036487; PMID:30467747; PMID:31916403; PMID:34664771 |
| GO:0045931 | Positive regulation of mitotic cell cycle | Increases phenotype | PMID:32023790; PMID:32387340; PMID:35307500 |
| GO:0046034 | Atp metabolic process | Affects phenotype | PMID:32949729; PMID:33312107; PMID:34474090; PMID:37080528 |
| GO:0046082 | 5-methylcytosine biosynthetic process | Increases phenotype | PMID:30303745 |
| GO:0046110 | Xanthine metabolic process | Affects phenotype | PMID:31778932 |
| GO:0046209 | Nitric oxide metabolic process | Increases phenotype | PMID:30112920; PMID:30641872; PMID:31489946; PMID:32172062; PMID:32810514; PMID:33024228; PMID:33408296; PMID:34434659; PMID:34797181; PMID:36336871 |
| GO:0046325 | Negative regulation of glucose import | Increases phenotype | PMID:30133442; PMID:32976960 |
| GO:0046326 | Positive regulation of glucose import | Increases phenotype | PMID:36328215 |
| GO:0046329 | Negative regulation of jnk cascade | Increases phenotype | PMID:30036487 |
| GO:0046415 | Urate metabolic process | Affects phenotype | PMID:31091348 |
| GO:0046449 | Creatinine metabolic process | Increases phenotype | PMID:30997025; PMID:31091348; PMID:31091348; PMID:33985639; PMID:39722417; PMID:39722417 |
| GO:0046460 | Neutral lipid biosynthetic process | Increases phenotype | PMID:27014939 |
| GO:0046462 | Monoacylglycerol metabolic process | Affects phenotype | PMID:33243495 |
| GO:0046466 | Membrane lipid catabolic process | Increases phenotype | PMID:12767684; PMID:36858637 |
| GO:0046470 | Phosphatidylcholine metabolic process | Affects phenotype | PMID:38048832; PMID:38882385 |
| GO:0046620 | Regulation of organ growth | Affects phenotype | PMID:32145629 |
| GO:0046621 | Negative regulation of organ growth | Increases phenotype | PMID:32145629; PMID:35005817; PMID:35278557; PMID:36315628 |
| GO:0046622 | Positive regulation of organ growth | Affects phenotype | PMID:27473340; PMID:27830003; PMID:29323181; PMID:29596923; PMID:30228064; PMID:30675821; PMID:32488702; PMID:32145629; PMID:32488702; PMID:32518293; PMID:32540565; PMID:36214340 |
| GO:0046627 | Negative regulation of insulin receptor signaling pathway | Increases phenotype | PMID:29793316 |
| GO:0046697 | Decidualization | Decreases phenotype | PMID:28729173; PMID:29605410 |
| GO:0046827 | Positive regulation of protein export from nucleus | Increases phenotype | PMID:27384303 |
| GO:0046881 | Positive regulation of follicle-stimulating hormone secretion | Increases phenotype | PMID:35567931; PMID:37364641; PMID:37448361 |
| GO:0046884 | Follicle-stimulating hormone secretion | Decreases phenotype | PMID:30245359 |
| GO:0046903 | Secretion | Increases phenotype | PMID:32753632 |
| GO:0046959 | Habituation | Decreases phenotype | PMID:34601267 |
| GO:0047810 | D-alanine:2-oxoglutarate aminotransferase activity | Increases phenotype | PMID:26450347 |
| GO:0047823 | D-glutamyltransferase activity | Increases phenotype | PMID:29477810 |
| GO:0048041 | Focal adhesion assembly | Increases phenotype | PMID:25096985; PMID:25096985; PMID:32325111; PMID:32325111 |
| GO:0048137 | Spermatocyte division | Decreases phenotype | PMID:30245210 |
| GO:0048143 | Astrocyte activation | Increases phenotype | PMID:33254826 |
| GO:0048484 | Enteric nervous system development | Affects phenotype | PMID:36615857 |
| GO:0048545 | Response to steroid hormone | Increases phenotype | PMID:30387366 |
| GO:0048663 | Neuron fate commitment | Decreases phenotype | PMID:29479338 |
| GO:0048699 | Generation of neurons | Affects phenotype | PMID:36615857 |
| GO:0048729 | Tissue morphogenesis | Affects phenotype | PMID:35598803 |
| GO:0048858 | Cell projection morphogenesis | Increases phenotype | PMID:35250464 |
| GO:0048870 | Cell motility | Affects phenotype | PMID:24231043; PMID:24347325; PMID:24460192 |
| GO:0048873 | Homeostasis of number of cells within a tissue | Decreases phenotype | PMID:35598803 |
| GO:0048874 | Host-mediated regulation of intestinal microbiota composition | Increases phenotype | PMID:29778027 |
| GO:0050000 | Chromosome localization | Decreases phenotype | PMID:30980863 |
| GO:0050665 | Hydrogen peroxide biosynthetic process | Increases phenotype | PMID:30352396; PMID:31344369; PMID:31387175 |
| GO:0050673 | Epithelial cell proliferation | Increases phenotype | PMID:32353937 |
| GO:0050679 | Positive regulation of epithelial cell proliferation | Increases phenotype | PMID:26260748 |
| GO:0050729 | Positive regulation of inflammatory response | Increases phenotype | PMID:24824810; PMID:33847390; PMID:38029875; PMID:39788208 |
| GO:0050746 | Regulation of lipoprotein metabolic process | Decreases phenotype | PMID:28959593 |
| GO:0050765 | Negative regulation of phagocytosis | Increases phenotype | PMID:29718165; PMID:35628159 |
| GO:0050767 | Regulation of neurogenesis | Affects phenotype | PMID:34049886 |
| GO:0050768 | Negative regulation of neurogenesis | Increases phenotype | PMID:35069845 |
| GO:0050808 | Synapse organization | Decreases phenotype | PMID:32512148 |
| GO:0050810 | Regulation of steroid biosynthetic process | Affects phenotype | PMID:28973422 |
| GO:0050890 | Cognition | Decreases phenotype | PMID:34314248; PMID:34788942 |
| GO:0050996 | Positive regulation of lipid catabolic process | Increases phenotype | PMID:33847390; PMID:33847390; PMID:37682394; PMID:35567931; PMID:35887390; PMID:36153926; PMID:36153926; PMID:38440074; PMID:37448361; PMID:37682394; PMID:37715411; PMID:38042274; PMID:38103660; PMID:38440074; PMID:39117098; PMID:39260547; PMID:39549767 |
| GO:0051001 | Negative regulation of nitric-oxide synthase activity | Increases phenotype | PMID:29960846 |
| GO:0051092 | Positive regulation of nf-kappab transcription factor activity | Increases phenotype | PMID:27522653 |
| GO:0051170 | Import into nucleus | Increases phenotype | PMID:31415812 |
| GO:0051225 | Spindle assembly | Affects phenotype | PMID:28178360; PMID:30980863 |
| GO:0051298 | Centrosome duplication | Increases phenotype | PMID:36384894 |
| GO:0051301 | Cell division | Increases phenotype | PMID:31011801 |
| GO:0051306 | Mitotic sister chromatid separation | Increases phenotype | PMID:36384894 |
| GO:0051315 | Attachment of mitotic spindle microtubules to kinetochore | Decreases phenotype | PMID:30980863 |
| GO:0051320 | S phase | Affects phenotype | PMID:30615907 |
| GO:0051321 | Meiotic cell cycle | Affects phenotype | PMID:26863571 |
| GO:0051345 | Positive regulation of hydrolase activity | Increases phenotype | PMID:32428650 |
| GO:0051346 | Negative regulation of hydrolase activity | Affects phenotype | PMID:32428650 |
| GO:0051491 | Positive regulation of filopodium assembly | Increases phenotype | PMID:38555994 |
| GO:0051496 | Positive regulation of stress fiber assembly | Increases phenotype | PMID:39527977 |
| GO:0051568 | Histone h3-k4 methylation | Increases phenotype | PMID:36347119 |
| GO:0051598 | Meiotic recombination checkpoint signaling | Increases phenotype | PMID:25181051 |
| GO:0051607 | Defense response to virus | Decreases phenotype | PMID:37855322 |
| GO:0051726 | Regulation of cell cycle | Increases phenotype | PMID:31750923 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Increases phenotype | PMID:24105817; PMID:24905940; PMID:24905940; PMID:24909818; PMID:25101517; PMID:26512966; PMID:30641872; PMID:30841469; PMID:32976987; PMID:33509759; PMID:33582411; PMID:34186417; PMID:35439536; PMID:36336871; PMID:36549428; PMID:36966614; PMID:37394128; PMID:37718616; PMID:37834465; PMID:38421590; PMID:39216304 |
| GO:0051882 | Mitochondrial depolarization | Increases phenotype | PMID:31404653; PMID:31830493; PMID:38029875 |
| GO:0051897 | Positive regulation of protein kinase b signaling | Increases phenotype | PMID:23900028 |
| GO:0051899 | Membrane depolarization | Increases phenotype | PMID:31312012; PMID:36549428 |
| GO:0051901 | Positive regulation of mitochondrial depolarization | Increases phenotype | PMID:29214717; PMID:30036487 |
| GO:0051951 | Positive regulation of glutamate uptake involved in transmission of nerve impulse | Decreases phenotype | PMID:28572023 |
| GO:0051965 | Positive regulation of synapse assembly | Increases phenotype | PMID:29278848 |
| GO:0055069 | Zinc ion homeostasis | Affects phenotype | PMID:32394729; PMID:33645299 |
| GO:0055070 | Copper ion homeostasis | Decreases phenotype | PMID:27690074; PMID:32394729; PMID:33645299 |
| GO:0055072 | Iron ion homeostasis | Decreases phenotype | PMID:27690074; PMID:38103660; PMID:38326183 |
| GO:0055074 | Calcium ion homeostasis | Decreases phenotype | PMID:18521933; PMID:20499049; PMID:26096086; PMID:26916392; PMID:27189055; PMID:27690074; PMID:28143888; PMID:28324061; PMID:28858478; PMID:29935216; PMID:30953815 |
| GO:0055088 | Lipid homeostasis | Decreases phenotype | PMID:32353385; PMID:33243495 |
| GO:0055089 | Fatty acid homeostasis | Decreases phenotype | PMID:32339907; PMID:33243495; PMID:35622622 |
| GO:0055091 | Phospholipid homeostasis | Affects phenotype | PMID:33243495; PMID:35890622; PMID:37718616 |
| GO:0060004 | Reflex | Decreases phenotype | PMID:25595991 |
| GO:0060009 | Sertoli cell development | Increases phenotype | PMID:30245210 |
| GO:0060011 | Sertoli cell proliferation | Decreases phenotype | PMID:30245210 |
| GO:0060047 | Heart contraction | Decreases phenotype | PMID:31566189 |
| GO:0060048 | Cardiac muscle contraction | Decreases phenotype | PMID:32144343 |
| GO:0060081 | Membrane hyperpolarization | Increases phenotype | PMID:28143888 |
| GO:0060137 | Maternal process involved in parturition | Decreases phenotype | PMID:30629253 |
| GO:0060138 | Fetal process involved in parturition | Affects phenotype | PMID:38431166 |
| GO:0060179 | Male mating behavior | Decreases phenotype | PMID:19906654; PMID:24265451 |
| GO:0060180 | Female mating behavior | Increases phenotype | PMID:24403293; PMID:31132128 |
| GO:0060206 | Estrous cycle phase | Affects phenotype | PMID:31129395 |
| GO:0060207 | Diestrus | Increases phenotype | PMID:31129395; PMID:32407858; PMID:38200540 |
| GO:0060208 | Proestrus | Decreases phenotype | PMID:31129395; PMID:36136478 |
| GO:0060209 | Estrus | Affects phenotype | PMID:24576723; PMID:29305326; PMID:36136478 |
| GO:0060210 | Metestrus | Increases phenotype | PMID:31129395; PMID:36136478 |
| GO:0060291 | Long-term synaptic potentiation | Affects phenotype | PMID:32714078 |
| GO:0060292 | Long-term synaptic depression | Increases phenotype | PMID:23645310 |
| GO:0060322 | Head development | Increases phenotype | PMID:21900077 |
| GO:0060326 | Cell chemotaxis | Increases phenotype | PMID:32466334; PMID:32981897; PMID:33469997; PMID:37080528; PMID:38091676; PMID:38372072 |
| GO:0060348 | Bone development | Decreases phenotype | PMID:28772150; PMID:34097993 |
| GO:0060395 | Smad protein signal transduction | Increases phenotype | PMID:27740625 |
| GO:0060443 | Mammary gland morphogenesis | Affects phenotype | PMID:26903627; PMID:32353937 |
| GO:0060444 | Branching involved in mammary gland duct morphogenesis | Increases phenotype | PMID:27178563 |
| GO:0060526 | Prostate glandular acinus morphogenesis | Affects phenotype | PMID:26260748 |
| GO:0060545 | Positive regulation of necroptotic process | Increases phenotype | PMID:30238673; PMID:37422542 |
| GO:0060548 | Negative regulation of cell death | Increases phenotype | PMID:37487893 |
| GO:0060587 | Regulation of lipoprotein lipid oxidation | Increases phenotype | PMID:39549767 |
| GO:0060603 | Mammary gland duct morphogenesis | Decreases phenotype | PMID:15919749; PMID:28938483 |
| GO:0060612 | Adipose tissue development | Increases phenotype | PMID:20019905; PMID:27187982; PMID:31551937; PMID:34165232; PMID:34165232; PMID:36469784; PMID:39886984 |
| GO:0060613 | Fat pad development | Affects phenotype | PMID:27641926; PMID:29220483 |
| GO:0060737 | Prostate gland morphogenetic growth | Increases phenotype | PMID:31771501 |
| GO:0060741 | Prostate gland stromal morphogenesis | Affects phenotype | PMID:26260748 |
| GO:0060746 | Parental behavior | Decreases phenotype | PMID:30003164 |
| GO:0060763 | Mammary duct terminal end bud growth | Increases phenotype | PMID:11566746; PMID:32353937; PMID:27178563; PMID:28487351 |
| GO:0060935 | Cardiac fibroblast cell differentiation | Increases phenotype | PMID:25862758 |
| GO:0060996 | Dendritic spine development | Decreases phenotype | PMID:34838597 |
| GO:0060999 | Positive regulation of dendritic spine development | Increases phenotype | PMID:29278848 |
| GO:0061002 | Negative regulation of dendritic spine morphogenesis | Increases phenotype | PMID:32027964; PMID:32278051 |
| GO:0061028 | Establishment of endothelial barrier | Affects phenotype | PMID:32144343 |
| GO:0061053 | Somite development | Decreases phenotype | PMID:31756439 |
| GO:0061179 | Negative regulation of insulin secretion involved in cellular response to glucose stimulus | Increases phenotype | PMID:38844119 |
| GO:0061370 | Testosterone biosynthetic process | Increases phenotype | PMID:23984391; PMID:24024361; PMID:33802611; PMID:38021376; PMID:24134786; PMID:28641706; PMID:24305612; PMID:35429613; PMID:35465754; PMID:36864339; PMID:37915476; PMID:38513920; PMID:24786630; PMID:25112706; PMID:29778459; PMID:27296223; PMID:28739533; PMID:30557795; PMID:27383665; PMID:28482050; PMID:28697429; PMID:28970132; PMID:29778459; PMID:30275377; PMID:29501275; PMID:31263496; PMID:31352099; PMID:31424294; PMID:31979393; PMID:33173981; PMID:33297044; PMID:33753083; PMID:33802611; PMID:38021376; PMID:33967032; PMID:34601267; PMID:35187753; PMID:35427877; PMID:35429613; PMID:35465754; PMID:35465754; PMID:36864339; PMID:37915476; PMID:38513920; PMID:38513920 |
| GO:0061518 | Microglial cell proliferation | Increases phenotype | PMID:35250464 |
| GO:0061519 | Macrophage homeostasis | Affects phenotype | PMID:37510359 |
| GO:0061526 | Acetylcholine secretion | Decreases phenotype | PMID:34655688 |
| GO:0061548 | Ganglion development | Affects phenotype | PMID:36982030 |
| GO:0061827 | Sperm head | Affects phenotype | PMID:38882385 |
| GO:0070050 | Neuron cellular homeostasis | Affects phenotype | PMID:35489422; PMID:39000048 |
| GO:0070059 | Intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | Increases phenotype | PMID:35940389 |
| GO:0070091 | Glucagon secretion | Decreases phenotype | PMID:34165232; PMID:36674557 |
| GO:0070174 | Negative regulation of enamel mineralization | Increases phenotype | PMID:23764278; PMID:27257137 |
| GO:0070254 | Mucus secretion | Decreases phenotype | PMID:30841469 |
| GO:0070265 | Necrotic cell death | Increases phenotype | PMID:28689058; PMID:28689058; PMID:37570835; PMID:37372067; PMID:37394128; PMID:37570835; PMID:37915476; PMID:38513920 |
| GO:0070266 | Necroptotic process | Increases phenotype | PMID:32144343; PMID:36549428 |
| GO:0070288 | Ferritin complex | Increases phenotype | PMID:38882385 |
| GO:0070296 | Sarcoplasmic reticulum calcium ion transport | Affects phenotype | PMID:24569941 |
| GO:0070327 | Thyroid hormone transport | Decreases phenotype | PMID:28119167 |
| GO:0070328 | Triglyceride homeostasis | Decreases phenotype | PMID:27502578; PMID:32540565; PMID:28959593; PMID:32339907; PMID:30057697; PMID:32540565; PMID:33243495; PMID:33315269; PMID:33315269; PMID:34505250; PMID:36137816; PMID:35341816; PMID:35739755; PMID:36137816 |
| GO:0070341 | Fat cell proliferation | Increases phenotype | PMID:25909471; PMID:33265944 |
| GO:0070343 | White fat cell proliferation | Increases phenotype | PMID:37105096 |
| GO:0070371 | Erk1 and erk2 cascade | Increases phenotype | PMID:24189132; PMID:24349194 |
| GO:0070373 | Negative regulation of erk1 and erk2 cascade | Increases phenotype | PMID:29778459; PMID:30036487 |
| GO:0070374 | Positive regulation of erk1 and erk2 cascade | Increases phenotype | PMID:23900028; PMID:26363202; PMID:28255459; PMID:30022450 |
| GO:0070471 | Uterine smooth muscle contraction | Decreases phenotype | PMID:23664861 |
| GO:0070509 | Calcium ion import | Increases phenotype | PMID:28701262; PMID:28924161; PMID:30707916 |
| GO:0070585 | Protein localization to mitochondrion | Increases phenotype | PMID:30615907 |
| GO:0070665 | Positive regulation of leukocyte proliferation | Increases phenotype | PMID:29427786; PMID:29428349 |
| GO:0070813 | Hydrogen sulfide metabolic process | Affects phenotype | PMID:34314248 |
| GO:0070859 | Positive regulation of bile acid biosynthetic process | Increases phenotype | PMID:37211107 |
| GO:0070958 | Negative regulation of neutrophil mediated killing of gram-positive bacterium | Increases phenotype | PMID:30088793 |
| GO:0070992 | Translation initiation complex | Affects phenotype | PMID:33431410 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:26450347; PMID:30678825; PMID:32144343; PMID:33173981; PMID:33582552; PMID:34314248; PMID:34793900; PMID:35187753; PMID:35461094; PMID:35940389; PMID:36206637; PMID:36206637; PMID:39722417; PMID:36633214; PMID:36966614; PMID:37570835; PMID:37570835; PMID:39722417; PMID:37915476; PMID:38513920; PMID:38027817; PMID:38421590; PMID:38513920; PMID:39722417 |
| GO:0071391 | Cellular response to estrogen stimulus | Increases phenotype | PMID:24284790 |
| GO:0071494 | Cellular response to uv-c | Affects phenotype | PMID:26982218 |
| GO:0071514 | Genomic imprinting | Decreases phenotype | PMID:23593014; PMID:24034936 |
| GO:0071542 | Dopaminergic neuron differentiation | Decreases phenotype | PMID:27271280 |
| GO:0071599 | Otic vesicle development | Decreases phenotype | PMID:31756439 |
| GO:0071625 | Vocalization behavior | Affects phenotype | PMID:32297422 |
| GO:0071674 | Mononuclear cell migration | Increases phenotype | PMID:34067838 |
| GO:0071743 | Ige immunoglobulin complex, circulating | Increases phenotype | PMID:32909835 |
| GO:0071838 | Cell proliferation in bone marrow | Decreases phenotype | PMID:31788436 |
| GO:0071897 | Dna biosynthetic process | Decreases phenotype | PMID:22125951 |
| GO:0071902 | Positive regulation of protein serine/threonine kinase activity | Increases phenotype | PMID:27539358 |
| GO:0072079 | Nephron tubule formation | Decreases phenotype | PMID:36206637 |
| GO:0072089 | Stem cell proliferation | Affects phenotype | PMID:24424067; PMID:35479511 |
| GO:0072520 | Seminiferous tubule development | Decreases phenotype | PMID:30275377; PMID:31201698; PMID:33173981; PMID:33802611; PMID:38882385; PMID:35700937; PMID:37364641; PMID:39549767 |
| GO:0072539 | T-helper 17 cell differentiation | Increases phenotype | PMID:32911021 |
| GO:0072540 | T-helper 17 cell lineage commitment | Increases phenotype | PMID:32702508 |
| GO:0072593 | Reactive oxygen species metabolic process | Increases phenotype | PMID:18246544; PMID:18521933; PMID:20553123; PMID:20815788; PMID:24472609; PMID:24625398; PMID:24705360; PMID:24768697; PMID:24909818; PMID:25344109; PMID:30641872; PMID:31916403; PMID:32023790; PMID:33265944; PMID:33437163; PMID:33485121; PMID:33582411; PMID:34186417; PMID:34439521; PMID:34474090; PMID:34748853; PMID:38211720; PMID:34797181; PMID:35563431; PMID:36336871; PMID:36549428; PMID:36613676; PMID:36966614; PMID:37257343; PMID:37718616; PMID:37843661; PMID:38211720; PMID:38326183; PMID:39322090; PMID:39736419 |
| GO:0072676 | Lymphocyte migration | Increases phenotype | PMID:31788436; PMID:34281243 |
| GO:0072677 | Eosinophil migration | Increases phenotype | PMID:31788436; PMID:32012983 |
| GO:0072682 | Eosinophil extravasation | Increases phenotype | PMID:24950052 |
| GO:0080090 | Regulation of primary metabolic process | Affects phenotype | PMID:30208560 |
| GO:0080182 | Histone h3-k4 trimethylation | Increases phenotype | PMID:25088689; PMID:25088689; PMID:27182052; PMID:27384303; PMID:28765096; PMID:29425287; PMID:33022573; PMID:35429613; PMID:36572933 |
| GO:0086003 | Cardiac muscle cell contraction | Increases phenotype | PMID:25723814; PMID:28324061 |
| GO:0086006 | Voltage-gated sodium channel activity involved in cardiac muscle cell action potential | Decreases phenotype | PMID:34240201 |
| GO:0090023 | Positive regulation of neutrophil chemotaxis | Increases phenotype | PMID:30088793; PMID:35533451 |
| GO:0090038 | Negative regulation of protein kinase c signaling | Increases phenotype | PMID:32380187 |
| GO:0090091 | Positive regulation of extracellular matrix disassembly | Increases phenotype | PMID:27925325 |
| GO:0090116 | C-5 methylation of cytosine | Increases phenotype | PMID:28496034; PMID:30015891; PMID:30044229; PMID:30126118; PMID:31610501; PMID:32105160 |
| GO:0090136 | Epithelial cell-cell adhesion | Decreases phenotype | PMID:33485121 |
| GO:0090181 | Regulation of cholesterol metabolic process | Increases phenotype | PMID:35887390; PMID:35945320; PMID:37211107 |
| GO:0090200 | Positive regulation of release of cytochrome c from mitochondria | Increases phenotype | PMID:34664771 |
| GO:0090207 | Regulation of triglyceride metabolic process | Increases phenotype | PMID:35945320; PMID:37211107 |
| GO:0090212 | Negative regulation of establishment of blood-brain barrier | Increases phenotype | PMID:34082316 |
| GO:0090240 | Positive regulation of histone h4 acetylation | Decreases phenotype | PMID:28067316 |
| GO:0090263 | Positive regulation of canonical wnt signaling pathway | Increases phenotype | PMID:29718440 |
| GO:0090297 | Positive regulation of mitochondrial dna replication | Increases phenotype | PMID:30194976 |
| GO:0090326 | Positive regulation of locomotion involved in locomotory behavior | Increases phenotype | PMID:32518293 |
| GO:0090398 | Cellular senescence | Increases phenotype | PMID:29275510 |
| GO:0090494 | Dopamine uptake | Increases phenotype | PMID:27494678 |
| GO:0090557 | Establishment of endothelial intestinal barrier | Decreases phenotype | PMID:32540565 |
| GO:0090648 | Response to environmental enrichment | Affects phenotype | PMID:31597243 |
| GO:0097006 | Regulation of plasma lipoprotein particle levels | Affects phenotype | PMID:27502578; PMID:39788208 |
| GO:0097050 | Type b pancreatic cell apoptotic process | Increases phenotype | PMID:24189131 |
| GO:0097062 | Dendritic spine maintenance | Decreases phenotype | PMID:30953815; PMID:38160929 |
| GO:0097198 | Histone h3-k36 trimethylation | Decreases phenotype | PMID:25748669; PMID:36347119 |
| GO:0097212 | Lysosomal membrane organization | Decreases phenotype | PMID:34186417 |
| GO:0097272 | Ammonium homeostasis | Decreases phenotype | PMID:35648353 |
| GO:0097298 | Regulation of nucleus size | Affects phenotype | PMID:33258555 |
| GO:0097327 | Response to antineoplastic agent | Decreases phenotype | PMID:28426875 |
| GO:0097621 | Monoamine oxidase activity | Decreases phenotype | PMID:22623521 |
| GO:0097676 | Histone h3-k36 dimethylation | Decreases phenotype | PMID:29718165; PMID:37315367 |
| GO:0097707 | Ferroptosis | Increases phenotype | PMID:38326183 |
| GO:0097722 | Sperm motility | Decreases phenotype | PMID:30321649; PMID:30755151; PMID:31489793; PMID:35465754; PMID:36347119; PMID:38922122; PMID:36966614; PMID:37105472; PMID:37105472; PMID:37682394; PMID:39549767; PMID:37682394; PMID:37915476; PMID:38513920; PMID:39549767 |
| GO:0097746 | Blood vessel diameter maintenance | Affects phenotype | PMID:34434659 |
| GO:0098532 | Histone h3-k27 trimethylation | Increases phenotype | PMID:36347119 |
| GO:0098582 | Innate vocalization behavior | Affects phenotype | PMID:29912934 |
| GO:0098609 | Cell-cell adhesion | Decreases phenotype | PMID:31230753 |
| GO:0098743 | Cell aggregation | Increases phenotype | PMID:27740625 |
| GO:0098781 | Ncrna transcription | Affects phenotype | PMID:29552716 |
| GO:0098868 | Bone growth | Decreases phenotype | PMID:29732168 |
| GO:0098928 | Presynaptic signal transduction | Affects phenotype | PMID:37495067 |
| GO:0098977 | Inhibitory chemical synaptic transmission | Increases phenotype | PMID:31997638 |
| GO:0099611 | Regulation of action potential firing threshold | Affects phenotype | PMID:31312012 |
| GO:0106292 | Superoxide-generating nadph oxidase activity | Increases phenotype | PMID:29214717 |
| GO:0110053 | Regulation of actin filament organization | Affects phenotype | PMID:31750923 |
| GO:0120041 | Positive regulation of macrophage proliferation | Decreases phenotype | PMID:29428349 |
| GO:0120193 | Tight junction organization | Decreases phenotype | PMID:32540565 |
| GO:0140042 | Lipid droplet formation | Increases phenotype | PMID:29721103; PMID:31016361; PMID:31470036; PMID:32540565; PMID:32623698; PMID:36670177; PMID:37755785; PMID:31551937; PMID:31661889; PMID:33847390; PMID:36597173; PMID:31661889; PMID:32220626; PMID:32353385; PMID:32623698; PMID:32623698; PMID:36466761; PMID:37046073; PMID:32763284; PMID:33203037; PMID:35736896; PMID:35996481; PMID:36466761; PMID:36597173; PMID:36670177; PMID:36830956; PMID:37105096; PMID:37701206; PMID:37755785 |
| GO:0140058 | Neuron projection arborization | Affects phenotype | PMID:27903287; PMID:33441873 |
| GO:0140059 | Dendrite arborization | Decreases phenotype | PMID:32027964 |
| GO:0140131 | Positive regulation of lymphocyte chemotaxis | Increases phenotype | PMID:29737898; PMID:35533451 |
| GO:0140253 | Cell-cell fusion | Increases phenotype | PMID:31278978 |
| GO:0140354 | Lipid import into cell | Affects phenotype | PMID:35005817; PMID:35739755; PMID:38388800; PMID:38555994; PMID:39260547 |
| GO:0140639 | Positive regulation of pyroptosis | Increases phenotype | PMID:35439536 |
| GO:0140949 | Histone h3k9 trimethyltransferase activity | Increases phenotype | PMID:31610501 |
| GO:0140951 | Histone h3k27 trimethyltransferase activity | Increases phenotype | PMID:31610501 |
| GO:0140952 | Histone h3k27 dimethyltransferase activity | Increases phenotype | PMID:36347119 |
| GO:0150063 | Visual system development | Decreases phenotype | PMID:31756439 |
| GO:0150071 | Negative regulation of arginase activity | Increases phenotype | PMID:32428650 |
| GO:0150072 | Positive regulation of arginase activity | Increases phenotype | PMID:32428650 |
| GO:0150078 | Positive regulation of neuroinflammatory response | Increases phenotype | PMID:34082316 |
| GO:0160020 | Positive regulation of ferroptosis | Increases phenotype | PMID:36153926; PMID:38103660 |
| GO:0160024 | Leydig cell proliferation | Increases phenotype | PMID:36214340 |
| GO:1900017 | Positive regulation of cytokine production involved in inflammatory response | Increases phenotype | PMID:29846729; PMID:30398665 |
| GO:1900110 | Negative regulation of histone h3-k9 dimethylation | Increases phenotype | PMID:31532523 |
| GO:1900113 | Negative regulation of histone h3-k9 trimethylation | Increases phenotype | PMID:31532523 |
| GO:1900114 | Positive regulation of histone h3-k9 trimethylation | Increases phenotype | PMID:30015891 |
| GO:1900182 | Positive regulation of protein localization to nucleus | Increases phenotype | PMID:27745655; PMID:33706241 |
| GO:1900193 | Regulation of oocyte maturation | Affects phenotype | PMID:29458137 |
| GO:1900194 | Negative regulation of oocyte maturation | Increases phenotype | PMID:29958887 |
| GO:1900271 | Regulation of long-term synaptic potentiation | Affects phenotype | PMID:28255459 |
| GO:1900272 | Negative regulation of long-term synaptic potentiation | Increases phenotype | PMID:29278848 |
| GO:1900273 | Positive regulation of long-term synaptic potentiation | Increases phenotype | PMID:28255459; PMID:29278848 |
| GO:1900408 | Negative regulation of cellular response to oxidative stress | Increases phenotype | PMID:32153214 |
| GO:1900409 | Positive regulation of cellular response to oxidative stress | Increases phenotype | PMID:36315628; PMID:39260547 |
| GO:1900745 | Positive regulation of p38mapk cascade | Increases phenotype | PMID:27743673; PMID:29793316; PMID:30015891 |
| GO:1900825 | Regulation of membrane depolarization during cardiac muscle cell action potential | Affects phenotype | PMID:38310357 |
| GO:1901142 | Insulin metabolic process | Affects phenotype | PMID:24705360; PMID:33315269 |
| GO:1901216 | Positive regulation of neuron death | Increases phenotype | PMID:32380187 |
| GO:1901224 | Positive regulation of nik/nf-kappab signaling | Increases phenotype | PMID:27522653 |
| GO:1901251 | Positive regulation of lung goblet cell differentiation | Increases phenotype | PMID:29737898 |
| GO:1901318 | Negative regulation of flagellated sperm motility | Increases phenotype | PMID:26862991; PMID:30245359; PMID:31532523; PMID:36315628 |
| GO:1901568 | Fatty acid derivative metabolic process | Affects phenotype | PMID:29627605 |
| GO:1901670 | Negative regulation of superoxide dismutase activity | Increases phenotype | PMID:30194976; PMID:30228064; PMID:30228064; PMID:39549767; PMID:31875995; PMID:33348264; PMID:34505250; PMID:34505250; PMID:35699857; PMID:34664771; PMID:35699857; PMID:35945320; PMID:39117098; PMID:39549767 |
| GO:1901671 | Positive regulation of superoxide dismutase activity | Affects phenotype | PMID:27539358; PMID:28259788; PMID:30228064; PMID:39260547 |
| GO:1901676 | Positive regulation of histone h3-k27 acetylation | Decreases phenotype | PMID:28067316 |
| GO:1901687 | Glutathione derivative biosynthetic process | Decreases phenotype | PMID:28959593; PMID:30057697 |
| GO:1901726 | Negative regulation of histone deacetylase activity | Increases phenotype | PMID:36534918 |
| GO:1901989 | Positive regulation of cell cycle phase transition | Increases phenotype | PMID:35041905 |
| GO:1902093 | Positive regulation of flagellated sperm motility | Decreases phenotype | PMID:27539358 |
| GO:1902225 | Negative regulation of acrosome reaction | Increases phenotype | PMID:38922122 |
| GO:1902412 | Regulation of mitotic cytokinesis | Decreases phenotype | PMID:36214340 |
| GO:1902465 | Negative regulation of histone h3-k27 trimethylation | Increases phenotype | PMID:29425287 |
| GO:1902466 | Positive regulation of histone h3-k27 trimethylation | Increases phenotype | PMID:27697584; PMID:30015891 |
| GO:1902512 | Positive regulation of apoptotic dna fragmentation | Increases phenotype | PMID:28959593; PMID:30228064 |
| GO:1902552 | Negative regulation of catalase activity | Increases phenotype | PMID:35699857; PMID:35945320; PMID:39117098; PMID:39549767 |
| GO:1902553 | Positive regulation of catalase activity | Increases phenotype | PMID:39260547 |
| GO:1902618 | Cellular response to fluoride | Increases phenotype | PMID:27257137 |
| GO:1902807 | Negative regulation of cell cycle g1/s phase transition | Increases phenotype | PMID:37105472 |
| GO:1902847 | Regulation of neuronal signal transduction | Affects phenotype | PMID:26934298 |
| GO:1902849 | Positive regulation of neuronal signal transduction | Increases phenotype | PMID:37392660 |
| GO:1902884 | Positive regulation of response to oxidative stress | Increases phenotype | PMID:33348264; PMID:35739755; PMID:39260547 |
| GO:1902957 | Negative regulation of mitochondrial electron transport, nadh to ubiquinone | Increases phenotype | PMID:35598803 |
| GO:1903047 | Mitotic cell cycle process | Decreases phenotype | PMID:30615907; PMID:30980863; PMID:31601247; PMID:31601247; PMID:32466334; PMID:32466334; PMID:33516137; PMID:34585602; PMID:35429799; PMID:36181250; PMID:36633214; PMID:36982678; PMID:38211720; PMID:38372072 |
| GO:1903078 | Positive regulation of protein localization to plasma membrane | Increases phenotype | PMID:33706241 |
| GO:1903087 | Mitotic spindle pole body duplication | Affects phenotype | PMID:36384894 |
| GO:1903142 | Positive regulation of establishment of endothelial barrier | Increases phenotype | PMID:32559890 |
| GO:1903209 | Positive regulation of oxidative stress-induced cell death | Increases phenotype | PMID:35622622 |
| GO:1903249 | Negative regulation of citrulline biosynthetic process | Increases phenotype | PMID:31489946 |
| GO:1903283 | Negative regulation of glutathione peroxidase activity | Increases phenotype | PMID:28490175; PMID:30057697; PMID:31875995; PMID:34505250; PMID:34505250; PMID:35699857; PMID:35699857 |
| GO:1903284 | Positive regulation of glutathione peroxidase activity | Affects phenotype | PMID:27539358; PMID:28259788; PMID:30228064; PMID:39260547 |
| GO:1903353 | Regulation of nucleus organization | Affects phenotype | PMID:31750923 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Affects phenotype | PMID:25101517; PMID:25693136; PMID:26512966; PMID:26916392; PMID:26982218; PMID:27189055; PMID:28709031; PMID:29128613; PMID:29275510; PMID:29964091; PMID:30841469; PMID:30953815; PMID:31387175; PMID:31424294; PMID:31453682; PMID:35427877 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Affects phenotype | PMID:25933419; PMID:26049153; PMID:26376105; PMID:28259788; PMID:29940534; PMID:30036487; PMID:30088793; PMID:30194976; PMID:32023790; PMID:32040846; PMID:32515636; PMID:33039870; PMID:34174261; PMID:34664771; PMID:35439536; PMID:35622622; PMID:36858637; PMID:37105472; PMID:37944787; PMID:38006930; PMID:38029875; PMID:38042274; PMID:38134982; PMID:38555994; PMID:38844119; PMID:39059691; PMID:39117098; PMID:39260547 |
| GO:1903537 | Meiotic cell cycle process involved in oocyte maturation | Decreases phenotype | PMID:28178360; PMID:40036665 |
| GO:1903626 | Positive regulation of dna catabolic process | Increases phenotype | PMID:35005817 |
| GO:1903703 | Enterocyte differentiation | Affects phenotype | PMID:38563870 |
| GO:1903709 | Uterine gland development | Increases phenotype | PMID:26898831; PMID:27473340; PMID:30892605 |
| GO:1903753 | Negative regulation of p38mapk cascade | Increases phenotype | PMID:30036487 |
| GO:1903786 | Regulation of glutathione biosynthetic process | Decreases phenotype | PMID:35887390 |
| GO:1903787 | Negative regulation of glutathione biosynthetic process | Increases phenotype | PMID:34505250; PMID:35567931; PMID:35945320; PMID:38042274; PMID:38440074 |
| GO:1903923 | Positive regulation of protein processing in phagocytic vesicle | Increases phenotype | PMID:30228064 |
| GO:1903966 | Monounsaturated fatty acid biosynthetic process | Affects phenotype | PMID:30145421 |
| GO:1904000 | Positive regulation of eating behavior | Affects phenotype | PMID:27641926; PMID:30057697 |
| GO:1904027 | Negative regulation of collagen fibril organization | Increases phenotype | PMID:37224931 |
| GO:1904028 | Positive regulation of collagen fibril organization | Increases phenotype | PMID:27925325 |
| GO:1904077 | Negative regulation of estrogen biosynthetic process | Increases phenotype | PMID:37944787 |
| GO:1904078 | Positive regulation of estrogen biosynthetic process | Decreases phenotype | PMID:27112698 |
| GO:1904109 | Positive regulation of cholesterol import | Increases phenotype | PMID:28057006 |
| GO:1904146 | Positive regulation of meiotic cell cycle process involved in oocyte maturation | Increases phenotype | PMID:29458137 |
| GO:1904179 | Positive regulation of adipose tissue development | Increases phenotype | PMID:27145005; PMID:27806752; PMID:29721103 |
| GO:1904196 | Negative regulation of granulosa cell proliferation | Increases phenotype | PMID:29958887 |
| GO:1904214 | Positive regulation of iodide transmembrane transport | Decreases phenotype | PMID:26827900 |
| GO:1904238 | Pericyte cell differentiation | Decreases phenotype | PMID:34884472 |
| GO:1904251 | Regulation of bile acid metabolic process | Increases phenotype | PMID:37211107 |
| GO:1904446 | Positive regulation of establishment of sertoli cell barrier | Decreases phenotype | PMID:26922907 |
| GO:1904598 | Positive regulation of connective tissue replacement involved in inflammatory response wound healing | Increases phenotype | PMID:35739755 |
| GO:1904659 | Glucose transmembrane transport | Affects phenotype | PMID:37080528 |
| GO:1904878 | Negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | Increases phenotype | PMID:30298846 |
| GO:1904879 | Positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | Increases phenotype | PMID:30298846 |
| GO:1904995 | Negative regulation of leukocyte adhesion to vascular endothelial cell | Increases phenotype | PMID:32559890 |
| GO:1905069 | Allantois development | Decreases phenotype | PMID:31756439 |
| GO:1905075 | Positive regulation of tight junction disassembly | Increases phenotype | PMID:34082316 |
| GO:1905523 | Positive regulation of macrophage migration | Increases phenotype | PMID:31143956 |
| GO:1905628 | Negative regulation of serotonin biosynthetic process | Increases phenotype | PMID:34082316 |
| GO:1905656 | Positive regulation of artery smooth muscle contraction | Increases phenotype | PMID:30298846 |
| GO:1905665 | Positive regulation of calcium ion import across plasma membrane | Increases phenotype | PMID:29476780 |
| GO:1905707 | Negative regulation of mitochondrial atp synthesis coupled proton transport | Affects phenotype | PMID:31536778 |
| GO:1905710 | Positive regulation of membrane permeability | Increases phenotype | PMID:31394344 |
| GO:1990138 | Neuron projection extension | Affects phenotype | PMID:27903287; PMID:31812737; PMID:33441873 |
| GO:1990182 | Exosomal secretion | Increases phenotype | PMID:39886984 |
| GO:1990349 | Gap junction-mediated intercellular transport | Increases phenotype | PMID:28087314; PMID:29458137; PMID:30187510; PMID:32610363; PMID:35413382 |
| GO:1990375 | Baculum development | Affects phenotype | PMID:37164221 |
| GO:1990748 | Cellular detoxification | Increases phenotype | PMID:28123100 |
| GO:1990834 | Response to odorant | Increases phenotype | PMID:30185693 |
| GO:1990911 | Response to psychosocial stress | Increases phenotype | PMID:30185693 |
| GO:2000018 | Regulation of male gonad development | Affects phenotype | PMID:29741722 |
| GO:2000111 | Positive regulation of macrophage apoptotic process | Increases phenotype | PMID:24189131 |
| GO:2000184 | Positive regulation of progesterone biosynthetic process | Decreases phenotype | PMID:27112698 |
| GO:2000224 | Regulation of testosterone biosynthetic process | Decreases phenotype | PMID:38440074 |
| GO:2000225 | Negative regulation of testosterone biosynthetic process | Increases phenotype | PMID:29940534; PMID:33297044; PMID:38538260; PMID:39239657 |
| GO:2000253 | Positive regulation of feeding behavior | Increases phenotype | PMID:32784060; PMID:36469784 |
| GO:2000278 | Regulation of dna biosynthetic process | Affects phenotype | PMID:31750923 |
| GO:2000304 | Positive regulation of ceramide biosynthetic process | Increases phenotype | PMID:39809339 |
| GO:2000321 | Positive regulation of t-helper 17 cell differentiation | Increases phenotype | PMID:27693988 |
| GO:2000323 | Negative regulation of glucocorticoid receptor signaling pathway | Increases phenotype | PMID:27522653 |
| GO:2000355 | Negative regulation of ovarian follicle development | Increases phenotype | PMID:29958887 |
| GO:2000375 | Negative regulation of oxygen metabolic process | Increases phenotype | PMID:29214717 |
| GO:2000376 | Positive regulation of oxygen metabolic process | Increases phenotype | PMID:31536778 |
| GO:2000388 | Positive regulation of antral ovarian follicle growth | Increases phenotype | PMID:28648634 |
| GO:2000391 | Positive regulation of neutrophil extravasation | Increases phenotype | PMID:29737898; PMID:32339907 |
| GO:2000421 | Positive regulation of eosinophil extravasation | Increases phenotype | PMID:27087817; PMID:29737898 |
| GO:2000424 | Positive regulation of eosinophil chemotaxis | Increases phenotype | PMID:35533451 |
| GO:2000439 | Positive regulation of monocyte extravasation | Increases phenotype | PMID:25862758 |
| GO:2000463 | Positive regulation of excitatory postsynaptic potential | Increases phenotype | PMID:28255459 |
| GO:2000469 | Negative regulation of peroxidase activity | Increases phenotype | PMID:29940534 |
| GO:2000538 | Positive regulation of b cell chemotaxis | Increases phenotype | PMID:35533451 |
| GO:2000609 | Regulation of thyroid hormone generation | Affects phenotype | PMID:32464474 |
| GO:2000610 | Negative regulation of thyroid hormone generation | Increases phenotype | PMID:29305326; PMID:32681327; PMID:37682394 |
| GO:2000617 | Positive regulation of histone h3-k9 acetylation | Affects phenotype | PMID:27478869; PMID:28067316; PMID:31610501 |
| GO:2000648 | Positive regulation of stem cell proliferation | Increases phenotype | PMID:30387366; PMID:35069845; PMID:36214340 |
| GO:2000786 | Positive regulation of autophagosome assembly | Increases phenotype | PMID:30228064; PMID:38006930 |
| GO:2000822 | Regulation of behavioral fear response | Affects phenotype | PMID:24333847 |
| GO:2000835 | Negative regulation of androgen secretion | Increases phenotype | PMID:38966215 |
| GO:2000844 | Negative regulation of testosterone secretion | Increases phenotype | PMID:29777495; PMID:29777495; PMID:30228064; PMID:35005817; PMID:35567931; PMID:29940534; PMID:35598803; PMID:36315628; PMID:35810996; PMID:37682394; PMID:39239657 |
| GO:2000845 | Positive regulation of testosterone secretion | Affects phenotype | PMID:25575453; PMID:27539358; PMID:28393075; PMID:29524480; PMID:30228064; PMID:30245359; PMID:34973380; PMID:36214340; PMID:37084542; PMID:37364641; PMID:37837293 |
| GO:2000853 | Negative regulation of corticosterone secretion | Increases phenotype | PMID:29737898 |
| GO:2000854 | Positive regulation of corticosterone secretion | Increases phenotype | PMID:26209791 |
| GO:2000863 | Positive regulation of estrogen secretion | Decreases phenotype | PMID:28959593 |
| GO:2000865 | Negative regulation of estradiol secretion | Increases phenotype | PMID:29228121; PMID:29777495; PMID:29958887; PMID:30194976; PMID:31753310; PMID:32488702; PMID:37084542; PMID:37448361; PMID:37837293 |
| GO:2000866 | Positive regulation of estradiol secretion | Increases phenotype | PMID:25575453; PMID:28393075; PMID:35598803; PMID:28648634; PMID:29323181; PMID:32380187; PMID:30245359; PMID:37084542; PMID:37364641; PMID:38440074; PMID:38966215 |
| GO:2000871 | Negative regulation of progesterone secretion | Increases phenotype | PMID:29228121; PMID:29777495; PMID:32488702; PMID:37448361; PMID:38966215 |
| GO:2000872 | Positive regulation of progesterone secretion | Increases phenotype | PMID:37084542 |
| GO:2000978 | Negative regulation of forebrain neuron differentiation | Increases phenotype | PMID:32027964 |
| GO:2000987 | Positive regulation of behavioral fear response | Increases phenotype | PMID:30185693 |
| GO:2001057 | Reactive nitrogen species metabolic process | Increases phenotype | PMID:31387175; PMID:33485121; PMID:36336871 |
| GO:2001170 | Negative regulation of atp biosynthetic process | Affects phenotype | PMID:29214717; PMID:38828519 |
| GO:2001171 | Positive regulation of atp biosynthetic process | Increases phenotype | PMID:30194976; PMID:35597549 |
| GO:2001246 | Negative regulation of phosphatidylcholine biosynthetic process | Increases phenotype | PMID:38029875 |
| GO:2001257 | Regulation of cation channel activity | Decreases phenotype | PMID:27125968 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.